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Abstract
There has been a growing interest in human microbiome studies in the past decade, with
the development of high-throughput sequencing techniques. These microorganisms
interact and respond to the host as an entity, and are involved in various homeostatic
functions including nutrition digestion, immune response, metabolism and endocrine
regulation. The urinary microbiome, however, remains relatively under-investigated.
One of the technical challenges of urinary microbiome studies is the samples usually
contain a large number of host cells and low microbial biomass. These samples with the
high host, low microbial abundance (“high-low” samples) are associated with increased
risk of compromised quality of 16s rRNA gene sequencing results. An analysis with
mock samples showed that mechanisms of host materials interfering with microbiome
analysis includes reducing microbial DNA extract yield by competitively binding to the
filter of DNA extraction column, inhibiting PCR amplification of 16S rRNA gene regions
as non-target DNA, and consuming sequencing depth by unspecific amplification from
PCR. To counter these issues, a refined processing protocol and a quality checking tool
were developed for handling “high-low” samples. With these methods, a combination of
sequencing-based methods and enhanced culture-based methods showed evidence of
bacteria in renal tissue samples.
On the other hand, the optimal urine sample collection and storage methods for
microbiome study have not been reported. An optimisation experiment showed that urine
samples with a volume higher than 20 mL and stored in centrifuged pellets generated the
best sequencing results.
The urinary microbiome of healthy subjects and urinary stone patients were characterised
using 16s rRNA gene sequencing and enhanced quantitative urine culture (EQUC)
techniques. Although no clear distinction was observed of urinary microbiome profiles
between healthy subjects and urinary stone patients, male and female individuals do have
their unique urinary microbiome profiles. The urinary microbiome profile of an
individual remained stable throughout three months.
i

Investigation of urine samples of metabolic stone patients before and after lithotripsy
showed fluctuations in their urinary microbiome profiles, with newly-emerged microbes
in sequencing results correlated with microbes cultured from stone samples. These results
suggested bacteria liberated from metabolic stones during lithotripsy.

Keywords
Urinary microbiome, Urinary microbiota, 16s rRNA gene sequencing, enhanced
quantitative urine culture, contamination, metagenomics, renal cell carcinoma, urinary
stones, metabolic stones
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Chapter 1

1

General Introduction

This chapter has been adapted with permission from:
•
•
•

Di Bella, J. M., Bao, Y., Gloor, G. B., Burton, J. P., & Reid, G. (2013). High throughput sequencing
methods and analysis for microbiome research. Journal of microbiological methods, 95(3), 401-414.
Bao, Y., Welk, B., Reid, G., & Burton, J. P. (2014). Role of the microbiome in recurrent urinary
tract infection. Novel Insights into Urinary Tract Infections and their Management, 49.
Bao, Y., Al, K. F., Chanyi, R. M., Whiteside, S., Dewar, M., Razvi, H., ... & Burton, J. P. (2017).
Questions and challenges associated with studying the microbiome of the urinary tract. Annals of
translational medicine, 5(2).

1.1 The human microbiome
The human microbiome is usually defined as all microbial populations (bacteria, fungi,
archaea, and viruses) together with their genes and genomes that inhabit the human body
(Turnbaugh et al., 2007). Another related term is “microbiota”, which refers to only the
bacteria present at a particular site. Lots of these microbes are commensal, and their
mutualistic relationship with the host has been reported. This relationship is more
apparent upon study of the gut microbiome, which contains the highest abundance of
microbes associated with any site in/on the human body. Within the gut, microorganisms
uptake nutrients primarily from ingested food, and fulfill a number of homeostatic
functions including the maintenance of barrier function, immune regulation, defence
against pathogens (Round & Mazmanian, 2009) and digestion of complex substances
from the human diet that are otherwise difficult to break down (Gill et al., 2006). Many
of these microorganisms may be potential pathogens, but it is believed that these
microbes are controlled and limited by the whole microbial ecosystem in the niche. The
components and structure of such microbial ecosystems may change over time, but in
most occasions, for a healthy subject, such a community maintains its relative stability
(Ley et al., 2006). Disruption of this stability could cause, or be the result of, a
“dysbiotic” state which usually links to pathological conditions including inflammatory
bowel disease (Garrett et al., 2010), dental caries (Ling et al., 2010), and obesity (Ley et
al., 2006).
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1.2 High throughput, culture-independent sequencing
methods for microbiome study
Our current understanding of the human microbiome has largely been due to the recent
advancements in sequencing technologies allowing for high-throughput assessment of
microbiome populations at relatively low cost. These studies have shown different body
sites have distinct microbiological communities, and these communities differ between
individuals (Turnbaugh et al., 2007).
Despite the fact that microbial cells vastly outnumber eukaryotic cells in the human body,
most of the microbes have not yet been cultivated (Amann et al., 1995). Therefore, most
uncultivated microorganisms remain to be fully characterized. With the recognition that
DNA sequences, particularly the 16S ribosomal gene sequence, are useful phylogenetic
markers and microbial identifiers, scientists are starting to gain an appreciation of the
complexity of microbial ecosystems (Pace et al., 1997 & 2009; Woese et al., 1987).
These developments, along with those of PCR and in situ hybridization, have led to a
shift toward culture-independent studies of microbial communities.

1.2.1 Common strategies of sequencing-based methods for
microbiome study
Three commonly used sequencing-based methods for investigating the microbiome are
amplicon, metagenome, and meta-transcriptome. In amplicon sequencing, a certain gene
or gene fragment is amplified, and the sequence is determined. This sequence is then used
as a comparator to other similar sequences within other microorganisms. If a highly
conserved genetic locus is chosen, such as segments of the 16S rRNA gene, the
organisms are able to be taxonomically identified. By comparing the organisms present
within multiple samples, researchers can identify how each differs within the
environment.
While amplicon-style analysis only depends on a single gene, to obtain more detailed
information regarding the particular sample, a metagenomic approach is used. Here, the
aim is to determine the total genetic composition of all microorganisms present in order
to make inferences about the functionalities or pathways present in these bacteria. With
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sufficient sequencing depth, metagenomic sequencing captures higher resolution
differentiating closely related organisms than 16s rRNA gene sequencing and is less
susceptible to PCR-associated bias (Poretsky et al., 2014). This technique can also be
utilized to explore the physiological capability of certain microbes in a sample with its
ability to obtain information of certain functional gene pathways. The main limitation of
metagenomic sequencing includes high cost and its dependence on gene library.
The previous two methods allow for the identification of the bacteria present in a sample,
or their genetic potential. However, these methods do not identify what these microbes
are functionally producing. For this, meta-transcriptome sequencing (RNA-Seq) is used.
All mRNA transcripts in a sample are sequenced and then analyzed to determine relative
or differential gene expression between different conditions or samples. All approaches
rely on a high-throughput sequencing technology, but differ in their sample preparation,
sequencing approach and bioinformatic analyses.
Studies of the microbiome require high-quality data to generate accurate results.
Therefore, each step of the processing streamline requires rigorous quality control,
including optimal sample collection methods, a sufficient number of samples, obtaining
samples from biologically relevant sites, controlling for confounding factors, choosing
appropriate sequencing platforms and using appropriate analytical tools. Each of these
factors will be discussed in later sections.

1.2.1.1

Sample collection and metadata acquisition.

Optimal methods for sample collection and storage vary for different sample types. For
microbe-rich samples such as stool, different collection and storage conditions yield
reproducible sequencing results (Al et al., manuscript under review). However, for
samples with low microbial biomass or samples in liquid or gaseous form, care should be
taken during processing to avoid compromising quality. Sequencing results of samples
with low microbial biomass are easily confounded by environmental or reagent
contamination (Salter et al., 2014), and in certain cases it is almost impossible to retrieve
an accurate profiling of the microbial community in the target niche (Kennedy et al.
2014; D. Kim et al., 2017; Salter et al., 2014). Liquid samples may require optimization
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for reliable storage. For example, when storing urine it is best to avoid cycles of freezing
and thawing as this process damages the cellular structure of microbes, and the DNA is
lost in the liquid phase of the sample. In such cases, concentrating the bacterial
component of the sample and storing in pellet form may be required.
Acquisition and recording of metadata is another very important factor. Metadata is any
information regarding the samples. The metadata can include but is not limited to where
the sample came from, when it was collected, how it was collected, the estimated
microbial abundance, risk of contamination of that environment, how that sample was
processed and sequenced. The metadata that should be collected depends on the nature of
the sample. With regards to a soil sample, it would be useful to record the latitude,
longitude, and depth where sampling occurred. Whereas for a human oral swab it would
be useful to record age, gender and all aspects of the health and/or disease status.
Metadata recording is becoming increasingly important as more metagenomic and metatranscriptomic sequences are submitted to databases; it is helpful to be able to search by a
disease state, habitat or other characteristics. It is also useful to have information stored
about the methods used to obtain the sequences, such as the sequencing platform used.
The Genome Standards Consortium has proposed checklists for metadata such as the
Minimum Information about any Sequence (MIxS), the Minimum Information about a
Marker Sequence (MIMARKS), and the Minimum Information about a Metagenome
Sequence (MIMS) checklists in order to standardize the metadata collected, as well as
“environmental packages” for specific sample types (Yilmaz et al., 2011). Beyond
submission to databases, metadata are also useful for any study in which samples are
being compared—the more metadata that are available, the more information a researcher
has about how the samples differ and how these might affect microbiome findings.

1.2.1.2

Nucleic acid extraction and library preparation

Microbial genomic DNA extraction and purification serve as the first step of library
preparation. Since most sequencing protocols require nanogram to microgram quantities
of DNA, efficient DNA isolation and purification is critical to ensure proper
representation of the microbial community present. Cell lysis and subsequent DNA
extraction from certain microbes, especially those living in extreme environments, can be
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difficult as these organisms have rigid cell wall structures and may also release stable
nucleases upon lysis. However, since such microbes are an interesting source for
bioprospecting new enzymes and other components, efforts are constantly made to
perform those challenging DNA extractions. With the application of mechanical lysis
(bead beating and sonicating), chemical lysis (Sodium dodecyl sulfate (SDS), phenol)
and enzymatic lysis (proteinase K, mutanolysin, etc.), high-quality DNA has been
retrieved from a variety of environments including soil (Hårdeman & Sjӧling, 2006;
Pathak et al., 2009; Voget et al., 2006; Waschkowitz et al., 2009), marine picoplankton
(Stein et al., 1996), saline soil (Purohit et al., 2009), contaminated subsurface sediments
(Abulencia et al., 2006), groundwater (Uchiyama et al., 2005), hotsprings, mud holes in
solfataric fields (Rhee et al., 2005) and many other locations. To avoid wasting expensive
reagents for library preparation and sequencing, the quantity and quality of the DNA need
to be confirmed before amplification and sequencing. Many different technologies exist
for measuring quality, such as the 2100 Bioanalyzer (Agilent Technologies), fluorimeters
(Qubit, Life Technologies), spectrometers (Nanodrop) and quantitative PCR for DNA
damage identification (Ginzinger et al., 2000). After verification of quality and quantity,
the DNA templates can go through further preparation steps.

1.2.1.3

High throughput sequencing methodologies

The first-generation DNA sequencing technology was developed by Sanger et al.(Sanger
et al., 1977) based on the selective incorporation of chain-terminating dideoxynucleotides
and required manual determination of the sequence. The first automatic sequencing
machine (AB370) was produced by Applied Biosystems in 1987 (L. Liu et al., 2012).
Using the Sanger technique, the first bacterial genome sequence was completed in 1995
(Fleischmann et al., 1995), and constituted the main part of the Human Genome Project
in 2001(Collins et al., 2003). These technical advancements promoted further
development of sequencing technology. With the launch of the Genome Sequencer 20
system by 454 Life Sciences in 2005, second-generation sequencing techniques came into
recognition with massively parallel analysis, high-throughput and reduced cost. This
significant advance reduced the difficulty of sequencing (Metzker et al., 2005) and made
it possible to analyze bacterial genomes in days rather than months or years (Loman et
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al., 2012). While most second-generation sequencing techniques rely on a sequencingby-synthesis design, the newly emerged third-generation sequencing techniques are
performed on a single-molecule basis with no initial DNA amplification step. The
features of each next-generation sequencing device are summarized in Table 1.1.

1.2.1.4

General considerations for high throughput sequencing

One of the first questions a scientist considering using high-throughput sequencing
should ask is: Is this methodology required to answer the scientific question? While the
sequencing is increasing in popularity, speed, reliability and decreasing in cost, it is not
always the appropriate tool to be used. For some experiments, other methods such as
microarrays may be appropriate and yield results that are more appropriate for the
specific hypotheses being addressed. However, because of its the depth and relatively
unbiased nature, the high-throughput sequencing technique is, in many cases, replacing
microarray technologies.
If sequencing is the appropriate tool, the second question is which platform should be
used. There are many different platforms on the market each with their distinct strengths
and weaknesses. Some may generate the largest total throughput per run, while others
may have better speed, read length or accuracy. The appropriate selection depends on the
aims of the experiment. In some cases, a combination of techniques could provide higher
coverage of the genome.
To increase the efficiency of sequencing, microbial samples are usually barcoded and
multiplexed. Understanding the complexity of your samples is critical to determine
whether multiplexing is needed and how many samples can be assayed in a single run. If
using a multiplexing approach, the concentration of each sample should be similar so that
equal amounts of data are achieved for each multiplexed sample.
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Table 1 Comparison of next-generation sequencing techniques

Sequencing Device

Chemistry

Read Length (bp)

Run Time

Throughput per run

Pyrosequencing

700

23h

700 Mb

Reads per run

High-end instruments
~1,000,000 shotgun,
454 GS FLX + (Roche)

~700,000 amplicon
High output: ~11 days

High output: 600 Gb

High output: 3 billion x 2

Rapid run: ~27h

Rapid run: 120 Gb

Rapid run: 600 million x 2

1x75 Frag, 2x50 MP

8 days

~320 Gb

1.4 billion x2

400

8h

35 Mb

HiSeq 2000/2500
(illumine)

Reversible
terminator

2 x 150

5500xl W SOLiD (Life
Technologies)

Ligation

Pyrosequencing

Bench-top devices
100,000 shotgun
454 GS Junior (Roche)

70,000 amplicon

Ion PGM (Life
Technologies)

MiSeq (Illumina)

Proteon
detection

Reversible
terminator

100 or 200

2x250

3h

27h

100 Mb (314 chip)

400-550 thousand (314 chip)

1 Gb (316 chip)

2-3 million (316 chip)

2 Gb (318 chip)

4-5.5 million (318 chip)

8.35 Gb

6.8 million (LRGC routinely
getting > 15M)
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1.2.2 Common applications of high-throughput sequencing and
bioinformatic tools
High-throughput sequencing techniques produce massive amounts of data. To determine
if and what conclusions can be made, it is necessary to analyze the information
computationally. In this section, the most commonly used methods and tools for targeted
amplicon sequencing analysis, shotgun metagenome analysis, and meta-transcriptome
analysis will be discussed, as well as what technologies are emerging. Figure 1 details a
summary of the steps for bioinformatic analyses for each of the different methodologies.
Amplicon sequencing will be the major focus going forward as this technology is the
primary one used for this thesis.

1.2.2.1

Targeted amplicon sequencing and analysis of bacterial
diversity

Amplifying and sequencing variable regions of highly conserved bacterial genes is a
common way to determine the taxonomic composition of a microbiome. By comparing
them to existing databases, one can determine from which organisms the sequences are
homologous to in order to make an inference into their identity, and thus determine the
bacterial profiles and proportions within a sample.

1.2.2.1.1

Amplicon choice

Typically, the gene encoding the 16S rRNA subunit is used to analyze prokaryotic
taxonomic composition in samples, as it is highly conserved in all prokaryotes. However,
since the 16S rRNA gene is approximately 1550 base pairs in length, it is difficult to
sequence the entirety of the gene using high-throughput sequencing methods without
requiring an assembly step. While techniques such as expectation maximization iterative
reconstruction of genes from the environment (EMIRGE) have been developed to
assemble the full 16S gene for taxonomic studies (Miller, Baker, Thomas, Singer, &
Banfield, 2011), it is not frequently used. Increasing the length of the sequence decreases
the depth of coverage, making it more difficult to assemble the gene and resolve rare
taxa.
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Figure 1 Flowchart detailing the steps in the bioinformatic analysis of sequence
data. Boxes in red represent steps for amplicon sequence analysis, boxes in yellow
represent steps for metagenome analysis, and boxes in blue represent steps for
meta-transcriptome analysis
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Instead, one or more of the nine variable (V) regions of the 16S rRNA gene are amplified
and sequenced. However, the variable regions differ between species in different ways—
some species can be distinguished in one variable region but not the other. Schloss et al.
reported that the use of different variable regions influences the way OTUs cluster and
the reported richness and evenness of communities. It was recommended to use caution
in the analysis of these data and that the data should not be analyzed in the same way that
one would analyze a full-length 16S rRNA gene sequence (Schloss et al., 2011). Kim et
al. reviewed and analyzed commonly used primers to determine how the use of different
variable regions for analysis affects OTU clustering, annotation, and estimates of
diversity when applied to sequences available from the Ribosomal Database Project
(RDP) database. It was concluded that it is easiest to analyze the V1–V3 or V1–V4
regions, as these are more variable and are better represented in the RDP database (Kim
et al., 2011). Liu et al. also compared several designs of 16S rRNA gene amplicon
sequencing and found that sequencing the V2–V3 regions produced the most accurate
results, as determined by modeling short read sequence data based on full 16S rRNA
gene sequences (Z. Liu et al., 2008). It was also suggested that several primers in
combination could be used (Z. Liu et al., 2008). Youssef et al. compared the effects of
the choice in the variable region on the amount of OTUs detected and found that V4, V5–
V6, and V6–V7 sequencing produces the best estimates for species richness in a sample
(Youssef et al., 2009). The Earth Microbiome Project (Gilbert et al., 2010) is
standardized to amplify the V4 region since the primers for that region are
complimentary homologous to most bacteria and archaea (www.earthmicrobiome.org).
Similar to the sequencing platform used, the choice of which variable region to amplify
depends on a variety of factors specific to the sample and experiment. This includes the
bacterial types likely present, level of taxonomic resolution (species, genus, or higher
taxonomic level), and the read length that is afforded by the sequencer. Further studies
relating to the effects of study design on the results of amplicon sequencing studies can
be found in the several publications (Mizrahi-Man et al., 2013; Shah et al., 2011; Soergel
et al. 2012).
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While the 16S rRNA gene is by far the most frequently used gene for studies of
community membership and structures, its use has limitations. One main criticism of the
technique is that many bacteria have more than one copy of the rrn operon, which
contains the 16S rRNA gene (Acinas et al., 2004). This is problematic for abundance
studies based on these sequences since bacteria with more 16S rRNA copies will be overrepresented in a sample. Also, there can be high levels of sequence divergence between
the multiple copies of the 16S rRNA gene present within the genome of a single
bacterium, in particular when examining extremophiles (Acinas et al., 2004). These
divergent sequences inflate the diversity estimates as their different rRNA genes make it
appear that multiple bacterial variants are present when in reality it is a single bacterium.
Lastly, many of the 16S rRNA gene primers are considered “universal” for all eubacterial
sequences despite the fact they may preferentially bind to sequences from some taxa over
others. This will also over-represent some taxa while under-representing others.
To combat these problems, other highly conserved genes have been used as an alternative
to the 16S rRNA gene. The most commonly used alternative is cpn60 that encodes the
type I chaperonin proteins. Previous research has shown that cpn60 sequencing has a
better resolution to distinguish species compared to the16S rRNA gene (Hill et al., 2010;
Schellenberg et al., 2009). However, in organisms with multiple copies of cpn60, they
tend to be even more divergent than 16S rRNA genes and can potentially inflate
taxonomic differences similarly to the case for multiple rRNA genes (Links et al., 2012).
For other highly conserved genes, such as rpoB, no universal primers exist making these
genes difficult to work with for studying the whole microbiome without bias. Another
major disadvantage of using alternatives to the 16S rRNA gene is that databases for these
genes are less well developed and thus annotation of the reads is more challenging (see
Section 1.2.2.1.5 for details on annotation).

1.2.2.1.2

Commonly used software packages and pipelines

Amplicon sequencing-based studies are becoming increasingly popular, and so a variety
of pipelines and tools have been developed to facilitate analyses. Most of the tools
described below can be found in these packages, allowing analysis of sequence data
without having to learn many different programs. The most popular pipelines are
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Quantitative Insights Into Microbial Ecology (QIIME)(Caporaso et al., 2010) and mothur
(Schloss et al., 2009). Each has the most common tools for analyses of amplicon
sequencing data.
For less common tools, the code is often available separately. One useful tool widely
used is the software environment known as R. This is an open source programming
language that is often used for statistical analyses and visualization of data (www.Rproject.org). Many software packages that are useful for analysis of microbiome data
have been developed for use in R, such as vegan, used for assessing diversity
(http://cran.r-project.org.proxy1.lib.uwo.ca/package=vegan), and phyloseq, used to
analyze operational taxonomic unit abundance data (McMurdie & Holmes, 2013).

1.2.2.1.3

Pre-processing of raw amplicon reads

All sequencing methods have some error. Amplicon sequencing analysis is particularly
vulnerable to erroneous conclusions caused by incorrectly sequenced reads, as errors in
raw sequence reads can lead to erroneously high estimates of bacterial diversity (Kunin et
al., 2010). Clustering reads based on sequence similarity counteracts some but not all of
these effects (Kunin et al., 2010). Because of this, pre-processing is often used before
further analysis.
Quality-based pre-processing methods are commonly used to filter out low-quality reads,
reducing the number of erroneous reads. Previous studies have filtered out reads with
ambiguous bases, mismatches to primers, low-quality scores, or minimal or no sequence
match to the amplified sequence (Huse et al., 2010). Another method that has been used
is to use quality scores to trim lengths of low-quality sequence from the reads (Kunin et
al., 2010), or trimming a fixed number of bases from the ends of reads. This is used
because sequence quality decreases with length and therefore this removes the lowest
quality data from each read.
For pyrosequencing methods such as Roche 454, additional tools exist to remove errors
due to these techniques' tendency to have insertions and/or deletions in their sequences at
homopolymeric tracts. Tools such as AmpliconNoise (Quince et al., 2011) and Denoiser
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(Reeder & Knight, 2010) analyze the flowgrams from the sequencers to detect potentially
erroneous reads.
Another source of sequence artifacts is chimeric sequences created during the PCR
amplification step. These forms when an aborted PCR product from one sequence binds
to and acts as the primer for the extension of another sequence, thus creating a hybrid
DNA molecule that was made from two templates (Hess et al., 2011). Like errors
introduced by sequencing, chimeric sequences can be falsely interpreted as novel
amplicons and thus incorrectly increase estimates of bacterial diversity (Huse et al.,
2010). Although the risk of chimeras forming is lower when sequencing variable regions,
it is still worthwhile to check for them. A number of tools exist to detect and remove
chimeric reads, including ChimeraSlayer that uses a reference set of amplicons (Hess et
al., 2011), Perseus, that acts de novo (Quince et al., 2011), and UCHIME, that can either
use a reference database or act de novo to detect chimeras (Edgar et al., 2011).

1.2.2.1.4

Operational taxonomic unit (OTU) clustering

It is incorrect to assume that each unique read represents a different species: mutations
and sequencing errors can lead to slightly different amplicon sequences within a species.
To prevent this from interfering, reads are aligned, and those that are similar are clustered
together forming operational taxonomic units (OTUs). The OTUs are defined by
clustering together sequences that are below a particular percentage of divergence from
each other. As this percentage increases, the number of reads clustered together increases,
as the percentage decreases the number of OTUs must also decrease. Clustering of
sequences in an OTU is a compromise between detecting more species than are actually
present (interpreting mutations and sequence errors as separate species), and detecting
fewer species than are actually present (clustering similar reads from different species
into separate OTUs). Generally, a 97% identity thresh-hold is used as an approximation
of species-level resolution. Meaning, all reads in a single OTU do not have greater than
3% sequence difference from each other (Stackebrandt & Goebel, 1994).
Since determining which OTU a sequence belongs to requires comparison of all input
sequences with each other, this procedure can take a large amount of computational
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power, and thus, a lot of time to complete. To make this task easier, pre-clustering is
performed. This involves collapsing all identical reads into one category; however, it is
important that the abundance information for these reads is stored for use in subsequent
quantitative analyses. Once the reads are pre-clustered, existing tools can be used to
determine OTUs.
There are two main independent approaches when assigning OTUs. The most commonly
used is de novo OTU picking, this technique compares all sequences to each other and
clusters them by similarity with no reference to outside sources of data. Cd-hit (W. Li &
Godzik, 2006), UCLUST(Edgar et al., 2010), ESPRIT-Tree (Cai & Sun, 2011), CROP
(Hao et al., 2011), BeBAC(Cheng et al., 2012), and M-pick (Wang et al. 2013) are all
tools that can choose OTUs independent of taxonomy. The other approach to OTU
picking is taxonomy-based where tools such as BLAST(Altschul et al., 1997) compare
sequences to a database and cluster OTUs based on their sequence similarity to known
sequences in the database. This approach is less likely to include erroneous sequences in
the analysis and immediately annotates the clustered reads; however, it discards reads
with sequences that do not match those in the database. This eliminates potentially novel
species. A third option is to combine the two approaches by using taxonomy-based OTU
picking first, and then using de novo clustering on the remaining reads (Bik et al., 2012).

1.2.2.1.5

Annotation

Once OTUs are determined, it is necessary to find out from what species they came. The
database used is dependent on the sequence amplified. For 16S rRNA gene sequences
several databases exist. The SILVA database has sequences for both the small and large
ribosomal subunits in prokaryotes as well as eukaryotes. Taxonomic classification of
rRNA sequences can be done using the SINA tool, available on its website(Pruesse et al.,
2007). The Ribosomal Database Project (RDP) contains prokaryotic 16S rRNA
sequences and has an RDP Classifier tool for taxonomic classification of rRNA gene
sequences, as well as several other tools for 16S rRNA amplicon processing and
analysis(Cole et al., 2008). GreenGenes also contains prokaryotic 16S rRNA sequences
along with a tool to compare sequences to the database (DeSantis et al., 2006). There are
fewer databases dedicated to other prokaryotic marker genes. For cpn60 sequences, the

15

cpnDB exists to aid annotation (Hill et al., 2004). For other markers, there are few or no
dedicated databases. In these cases, it is thought to be best to search against a general
purpose protein database.

1.2.2.1.6

Describing richness and evenness within samples

Richness is a description of the number of species present in a sample, while diversity is
a measure that combines richness with how evenly different species make up the sample's
microbiome. Richness may be determined by the number of OTUs present, but this can
be influenced by the sequencing depth, so metrics such as Chao1(Chao et al., 1984) and
ACE (Chao & Lee, 1992) are used to estimate the minimum number of species present in
the sample. Typically, the diversity within a sample is referred to as alpha-diversity. It is
measured using the Simpson diversity index and the Shannon diversity index; a detailed
description of alpha-diversity indices and application in microbiome research can be
found by Li et al. (Li et al., 2012).

1.2.2.1.7

Comparing samples

Diversity between samples is often referred to as beta-diversity. At its simplest, samples
can be compared by the OTUs shared, or by visualizing the relative abundance of
different OTUs in a heatmap. A more detailed approach can be used that considers
differences in species presence or absence, abundance, or phylogeny. This requires the
use of multivariate analyses. Commonly used tools and some emerging techniques are
described below. For a more detailed description of the statistical background of many
commonly used tools, the review by Remette et al. is helpful (Ramette et al., 2007).
To begin to compare samples, a distance matrix is made that quantifies the differences
between samples. This analyzes which taxa are present, and may or may not consider
phylogeny or abundance of different species. Phylogeny-independent metrics treat all
sequences equally regardless of their similarity. Sørensen's similarity matrices and the
Jaccard index measure differences qualitatively by determining the distance between
samples based on the presence or absence of OTUs. The Bray–Curtis and Morisita
similarity indices measure differences quantitatively based on the abundance of OTUs in
each sample (Chao et al., 2006). These metrics do not consider differences in sequencing
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depth, and so sequences must be normalized, or alternative methods that consider
unobserved species must be used (Chao et al., 2006; Engen et al., 2011). Conversely,
phylogeny-dependent metrics consider samples with more similar sequences to be more
similar. This is done by first putting the reads on a phylogenetic tree. This can be
constructed de novo by aligning and comparing samples, or by using a previously
constructed reference tree. A good reference tree may more accurately represent the
phylogenetic difference between species; however, a de novo tree will allow analysis of
sequences that do not match anything on the reference tree. The most commonly used
phylogeny-dependent similarity metric is the UniFrac distance. The unweighted UniFrac
distance considers the similarity between sequences in the samples, but does not compare
the sequences' abundances between samples, while the weighted UniFrac distance
considers both the similarity between sequences and the sequences' abundances
(Lozupone, Lladser, Knights, Stombaugh, & Knight, 2011).
Once the distances between the samples can be determined, they can be compared by
their similarities. One approach is clustering the data by similarity. Methods such as the
neighbor-joining method or the unweighted pair-group method with arithmetic mean
(UPGMA) can be used to arrange the distance data into clusters of samples, that can then
be visualized as a dendrogram to show the samples that are most related. Squash
clustering is a novel method that uses the Kantorovich–Rubenstein distance (in
microbiome analyses this functions in a similar fashion as a weighted UniFrac distance)
to cluster samples by their similarity, taking into account similarity and phylogeny; this
method is available in the software package “guppy” (Matsen IV & Evans, 2013). Unlike
other methods, in a dendrogram constructed by squash clustering the distance drawn
between internal nodes (points that connect multiple samples) corresponds to the
difference between them.
Another approach to comparing samples is the use of principal coordinates analysis
(PCoA). Here, the points (i.e., the samples) are plotted in multidimensional space so that
the distance between them is as close as possible to that in the distance matrix calculated
earlier. The direction in this multidimensional space that separates the points the most is
the first principal coordinate, the direction that separates the points second best is the
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second principal coordinate, and so on. Each principal coordinate has a percentage value
associated with it that represents the percent of the variation explained by that dimension.
One can plot the points where the axes represent the first and second principal
coordinates (and for a three-dimensional plot, the third principal coordinate). This allows
visualization of the distance data by reducing its dimensionality—points that cluster, in
this case, have more similar microbiomes as determined by the distance matrix
determined earlier. Points can be color-coded by metadata to qualitatively examine if
different types of samples cluster or form gradients along any components. Biplots can
then be used to show the abundance of different taxa and in which samples these taxa are
found.
A variation of this method was published recently, called edge principal components
analysis (edge PCA) (Matsen IV & Evans, 2013). Edge PCA uses a phylogeny-dependent
distance metric that considers the relatedness of taxa, and the resulting principal
components correspond to differences in particular clades of bacteria. This method
produces an edge PCA plot that can be interpreted in a similar way to a PCoA plot. It also
produces a phylogenetic tree of the organisms in the sample in which organisms that
drive a given principal component have their edges color-coded (by whether they
influence the principal component in the positive or negative direction) as well as having
different thicknesses of the edges depending on how much they drive that principal
component. This method is useful if differences in samples are driven by closely related
taxa. Edge PCA can be performed using the “guppy” software package.
The above methods are mainly exploratory. For more specific analysis, nonparametric
hypothesis testing tools are implemented. These include permutational multivariate
analysis of variance (PerMANOVA, also referred to as nonparametric multivariate
analysis of variance, NPMANOVA) (Anderson et al., 2001), analysis of similarity
(ANOSIM) (Claerke et al., 1993), and the Mantel test (Mantel et al., 1967). These can be
used with any distance metric to determine if the microbiome differs significantly
between groups of samples. Recently, parametric tools have been developed to test
hypotheses related to the microbiome, such as those found in the HMP R package. These
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tools are more powerful than the nonparametric tests but generally require pooling rare
taxa (La Rosa et al., 2012).

1.2.2.1.8

Describing interactions between bacteria

Amplicon sequencing and analysis can estimate the composition of different samples.
Therefore, one can theoretically determine interactions between bacteria, for example,
which bacteria co-occur and which co-exclude. However, this analysis is deceptively
challenging. Since abundances of bacteria determined by these methods are proportional
data, they are not independent; if one goes up, one or more others must go down.
Standard measures of correlation assume that the data are independent, thus it is not valid
to apply these to the proportional data, and doing so may result in spurious correlations
(Aitchison et al., 1986). Because of this, specialized tools must be made for these
analyses.
There is currently no tool to analyze co-occurrence or co-exclusion that is frequently used
in microbiome analysis, although some tools are under development. Faust et al. used a
novel analytic technique to determine co-occurrence and co-exclusion and analyze the
relationships' significance for human microbiome data; however, a computational tool to
analyze data in the same way was not developed (Faust et al., 2012). Friedman and Alm
produced a tool, SparCC (Friedman & Alm, 2012), that applies the log-ratio
transformation (Egozcue et al., 2003) to transform proportional data into independent
data and then approximates correlations to find co-occurring and co-excluding bacterial
pairs. The problem of determining co-occurrence and co-exclusion based on abundance
data is by no means resolved, and developing statistically sound methods that accurately
represent and interpret these data is an active area of research.

1.2.3 Future perspectives of high-throughput sequencing
High-throughput sequencing technologies have improved in output and quality, and have
become an indispensable tool for an increasingly wide variety of experiments, including
in phylogenetic, diagnostic, and ecological contexts. Through these tools, scientists can
gain insight into the composition, activities, and dynamics of a wide variety of
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microbiomes. This will help to elucidate how bacteria interact with each other and how
they interact with their environment.
Updates to the laboratory and computational tools are ongoing. In the near future, this
will result in sequencers that require less handling (e.g., removal of the amplification
step) in order to gain more automation and less error, while still maintaining high speeds
and throughputs with low costs and error rates. On the computational side, tools are
becoming faster and more specialized for multi-species samples, while also being able to
investigate new questions such as differential expression from high-throughput RNA
sequence data, genome assembly from metagenomic sequences, and interactions between
bacteria from amplicon sequence data. Many of these tools have a steep learning curve
for a biologist who is not computationally inclined, although specialized workflows are
being developed to allow analysis of these data without extensive computational
experience. As tools and statistical methodologies are refined, metagenomics and metatranscriptomics will be able to shift the focus of microbiome research from “Who is
here?” to “What are they doing?”. This will allow deeper insight into how bacteria
interact with their environment and each other. Incorporation of metabolomes, nutrients,
host genomes, and other metadata will allow the production of an incredibly detailed
picture of interactions between the microbiome and its environment, helping us
understand the role of prokaryotes in all environments in which they live.

1.3 Functional anatomy of the urinary tract
The urinary system dynamically exerts a cleaning and waste disposal function of the
human body. It is composed of the upper urinary tract (kidney and ureter) and lower
urinary tract (bladder and urethra). The two kidney resides bilaterally in the
retroperitoneal space, surrounded by renal capsule, perirenal fat, Gerota’s fascia and
pararenal fat. Being a bean-shaped organ, a kidney possesses a recessed area on the
concave border called renal hilum, where the renal vasculatures and ureter enters. The
kidney has high blood throughput, as it receives about 20% of the cardiac output, and
filters approximately 150 liters of blood per day, the condensed output contributing about
1.5 liters of urine after renal reabsorption, secretion and excretion. The urine is then
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emptied into the minor calyces by renal papilla, collected into the major calyces and renal
pelvis, and flows into the ureter.
The two ureters are long, tubular structures that connect the kidney to the urinary bladder.
The smooth muscle fibers in its wall form a peristaltic pressure wave that pushes the
urine moving forward. The urine flow rate at the ureter is about 0.5 to 5 ml per minute.
The ureteral peristalsis, together with the anti-reflux structure at ureterovesical junction
warrants the unidirectional flow of urine. This also serves as one of the defensive
mechanisms of the urinary system against bacterial ascension to the kidney.
The urinary bladder is a hollow organ located in the pelvis. It serves to contain urine,
making periodic voiding by alternative functioning of its detrusor and sphincter muscles.
Since the bladder is in close proximity to the exterior environment and urine in the
bladder remains relatively stationary, the bladder is the most common site for adult
urinary tract infections (UTIs). Because of this, the bladder possesses a vast catalogue of
defensive mechanisms that resist bacterial adhesion and colonization. Commonly
recognized lower urinary tract antibacterial defense mechanisms are listed in Table 2.
The urethra is the final pathway before urine exits the human body. The length of the
male urethra is approximately 20 cm while the female one is about 4 cm. Although
natural defenses against bacterial infection are present, the shorter urethral length in
females is a major contributing factor to their increased vulnerability to UTIs. Structural
abnormality of the urinary tract remarkably compromises its natural resistance to
bacterial invasion. Typically, urinary stasis is the direct result of the structural
abnormality, and is the core cause of UTI. Common causes of urinary obstruction are
listed in Table 3. Obstruction compromises the urine flow, and urinary stasis is a crucial
risk factor or infection. Urinary stones are a common cause of urinary stasis. Hormonal
and mechanical changes in the urinary system of pregnant women could lead to
physiological urinary stasis, making them among highest risk groups in females. For
males, the ones with congenital abnormalities and bladder outlet obstruction due to
benign prostate hypertrophy are usually prone to obstruction to the free flow of urine.
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Table 2. Antibacterial host defense mechanisms in the urinary tract (Jack D. Sobel,
2015)
Urine (osmolality, pH, organic acids)
Urine flow and micturition
Urinary tract mucosa (bactericidal activity, peptides, cytokines) - innate immunity
Inflammatory response
Polymorphonuclear neutrophils (PMNs)
Tamm-Horsfall protein
Cytokines
Low-molecular-weight oligosaccharides
Secretory immunoglobulin A (SIgA)
Lactoferrin
Peptides
Adaptive immune system, humoral immunity
Cell-mediated immunity
Miscellaneous prostatic secretions
Vesicoureteral reflux is another anomaly-associated risk factor for UTI. Urine reflux
contributes to upper urinary tract infection by promoting bacterial invasion via the
ascending route and perpetuates infections by inducing postvoid residual urine.
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Table 3. Common cause of urinary tract obstruction (Jack D. Sobel, 2015)
Extrarenal obstruction
Congenital anomalies of the ureter or urethra
Valves
Stenosis
Bands
Calculi
Extrinsic ureteral compression
Benign prostatic hypertrophy
Intrarenal obstruction
Nephrocalcinosis
Uric acid nephropathy
Analgesic nephropathy
Polycystic kidney disease
Hypokalemic nephropathy
Renal lesions of sickle cell trait/ disease
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1.4 Role of microbiota in recurrent urinary tract infections
(rUTI)
Urinary tract infections (UTIs) are the second most common bacterial infection in
humans. Of these, 20-25% of patients will experience a recurrence of their UTI (rUTI)
(Bsrsv Foxman, 1990). This can lead to considerable morbidity and health care costs.
Young, sexually active females are the most common sufferers of UTIs. About 50% of
women will experience a UTI at least once throughout their lifetime, of these, 20-25%
will experience rUTI and 3% will have this recurrence within six months following
treatment (Foxman et al., 2000). Known risk factors for rUTI include hormone
deficiency, diabetes, problems associated with urination, kidney stones and foreign
objects within urinary tracts (e.g. ureteral stents). Another less widely known factor is the
disruption of the vaginal microbiota, but it is believed this may also extend to other
potential reservoir sites, such as the rectum (Bergeron et al., 2012).

1.4.1 Etiology of rUTI
The cause and etiology of rUTI may be quite different between patient populations. For a
healthy young woman, the most common cause of rUTI is uropathogenic E.coli (UPEC)
of rectal origin colonization in the vagina, periurethral and distal urethra (Stamey et al.,
1971). Pediatric rUTIs are usually associated with conditions such as vesicoureteral
reflux (VUR) (Conway et al., 2007). Male rUTIs are relatively rare and may be
associated with urinary stasis following urinary tract obstruction, dysfunction and
instrumentation. Bacterial colonization in prostate also contributes to male UTI
recurrence (Carter, Levy, & Zeitlin, 2012).

1.4.2 Reservoirs for rUTI
Pathogens of rUTI typically originate from the rectum, sometimes replacing the normal
microbiota in the vagina. This occurs due to a state of microbiome flux, such as during
bacterial vaginosis, which allows these pathogens to colonize the periurethral area,
urethra and ascend into the bladder. Women with rUTI had a higher incidence of
uropathogens colonizing in the vagina with longer duration and higher severity compared
to women without rUTI, suggesting the role of the vagina in harboring uropathogenic
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strains that constantly invades urinary tract (Brumfitt et al., 1987). In fact, as high as 68%
of recurrences are caused by the same bacterial strain that caused the initial infection
(Foxman et al., 2000). It is documented that this same strain could take as long as three
years after the initial UTI to cause recurrence (Gillespie et al., 2000). In a normal vagina,
bacteria are present to prevent pathogens from causing infection. Lactobacillus crispatus
and Lactobacillus iners are the predominant species (Burton & Reid, 2002). It is known
these bacteria can prevent pathogens from multiplying to a symptomatic level by
releasing lactic acid, hydrogen peroxide (H2O2), and neutralizing uropathogens via
coaggregation effects (Reid et al., 1990). To cause initial infection, several daily
activities may facilitate bacteria migrating from the rectum into the vagina; wiping from
the anus towards the vagina after a bowel movement, retaining urine before voiding (i.e.,
not urinating when the initial urge is present), sexual intercourse and using a diaphragm
or spermicide for birth control. Women who experience rUTI often have specific vaginal
microbiota pattern shift. There is an increased proportion of E. coli and depletion of
normally predominant H2O2-producing lactobacilli (Gregor Reid et al., 2011). Although
it is not known when this shift occurs, it is possible it is not a result of the infection but
may predispose women to rUTI (Dwyer & O’reilly, 2002).

1.4.3 Pathogens of rUTI
Bacteria are the most common cause of UTIs, with UPEC causing the vast majority (up
to 90%) of all diagnosed cases (Schmiemann et al., 2010). When the first infection is
caused predominantly by E. coli, secondary UTIs may develop within six months due to
other organisms (Scholes et al., 2000). Other common uropathogens include
Staphylococcus saprophyticus, Enterococcus faecalis, Klebsiella pneumoniae, and
Proteus mirabilis (Grabe et al., 2009).

1.4.4 Pathophysiology of rUTI
1.4.4.1

Bacterial adhesion

Bacterial adhesion to host tissues serves as the first critical step in UTI pathogenesis.
UPECs express a wide variety of virulence factors, including adhesion factors,
hemolysin, siderophores and certain O antigens to exert their pathogenesis (Cadieux et
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al., 2009). UPEC can express two types of pili that adhere to specific receptors on the
uroepithelium. Interestingly, lactobacilli by-products have been shown to down-regulate
genes associated with these functions in UPEC strains (McMillan et al., 2012). The type
1 pilus adheres to mannosylated uroplakin proteins on the luminal surface of the bladder
(Wright & Hultgren, 2006), while P pili bind to globoseries glycolipids on the kidney
epithelial surfaces (Lane & Mobley, 2007). Some people are more susceptible to UTIs
based on a variety of factors. For example, individuals with an A, B, or AB blood type
are known as “non-secretors” as they do not secrete the normal antigens for that blood
type in bodily fluids. Non-secretors are more prone to recurrent UTIs because the cells
lining the vagina and urethra allow bacteria to attach more readily (Kinane et al., 1982).

1.4.4.2

Internalization and intracellular persistence of
uropathogens

Traditionally, bacteria responsible for UTIs were thought to exert their pathogenesis on
an extracellular basis. However, evidence now suggests UPEC strains encode
mechanisms to invade or be internalized by the host bladder epithelial and kidney
epithelial cells (Bishop et al., 2007). Similar invasive activities are observed in other
uropathogens, including S. saprophyticus (Szabados et al., 2008), K. pneumoniae (Rosen
et al., 2008), and S. enterica. Although the exact mechanism of invasion remains unclear
and might differ between pathogens, bacteria also take advantage endocytosis by the
epithelial cells (Bishop et al., 2007; Rosen et al., 2008). The pathogens avoid being
expelled by exocytosis and escape the endocytic compartments to enter the cytoplasm
(Eto et al., 2006). Once in the cytoplasm, they are able to multiply. Protected from the
host immune responses, pathogens can invade further into the underlying transitional
epithelium to establish a quiescent intracellular reservoir (QIR) that can serve as the
source of rUTIs (Hunstad & Justice, 2010). Studies based on murine models have
reported that the bacteria within a QIR persist for months after initial UTI (Schilling et
al., 2002), avoid host immune attack and systemic antibiotic therapy, and serve as the
source for rUTI without re-inoculation into the bladder (Agace et al., 1993).
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1.4.4.3

Immune evasion strategies of the pathogen

Unlike many other organs, the immune response of the bladder is characterized by
increased levels of urinary cytokines and neutrophil influx (Agace et al., 1993). This is
dependent upon the innate immune responses (Nielubowicz & Mobley, 2010) rather than
adapted responses (Chan, John, & Abraham, 2013). This, to some extent, explains why
chronic and recurrent UTI is common. The bladders’ innate immune response is initiated
by the activation of host pattern recognition receptors of the Toll-like receptor pathway,
including Toll-like receptor 4 (TLR4) (Schilling, Martin, Hung, Lorenz, & Hultgren,
2003). When urothelial cells expressing TLR4 recognizes lipopolysaccharide (LPS) from
Gram-negative bacteria, the proinflammatory and prosurvival NF-κB pathway is
activated, and chemokines/cytokines including IL-6 and IL-8 are secreted (Akira et al.,
2006). These inflammatory chemokines accumulate in the bladder mucosa and urine and
further induce an influx of neutrophils into the bladder and in turn phagocytosis and
clearance of bacteria. Though UPEC was reported to induce an adaptive immune
response in murine models (Thumbikat et al., 2006), pathogen-specific antibodies cannot
be detected in the serum and urine of patients with bladder-restricted infection
(Thumbikat et al., 2006).
Uropathogens can suppress inflammatory responses activated via TLR4 and other
receptors on the epithelial and bladder-resident immune effector cells. UPEC is able to
stabilize IκB and suppress NF-κB activity, thus hampering the increased apoptosis of
bladder epithelial cell upon exposure to UPEC (Klumpp et al., 2001), lowering
expression levels of IL-6 and IL-8, and suppressing secretion of these cytokines (Klumpp
et al., 2001). UPEC was also reported to downregulate the neutrophil gene related with
inflammatory signaling and in neutrophil chemotaxis, adhesion, and migration, thus
delaying neutrophil influx during very early stages of infection, facilitating bacterial
internalization (Klumpp et al., 2001). Interestingly, clinically isolated UPEC strains are
less susceptible to neutrophil killing in vitro and more resistant to reactive oxygen species
(ROS) and antibacterial peptides released by polymorphonuclear leukocytes and other
host cells in response to UPEC infection (Klumpp et al., 2001).
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1.4.5 Role of microbe in management for rUTI
1.4.5.1

Lactobacillus probiotics for rUTI

Since depletion of normal vaginal H2O2-producing lactobacilli is associated with
increased risks of UTI and recurrence, it seems to be a reasonable strategy to replete the
normal vaginal microbiota with lactobacilli to reduce the risk of UTI. Certain
Lactobacillus and avirulent E. coli species have been studied for their probiotic potential
(Barrons et al., 2007). Various clinical trials have reported to restore the protective
vaginal microbiota via oral (Beerepoot et al., 2012), intravaginal (Baerheim et al., 1994;
Reid et al., 1992; Reid et al., 1990) and direct intravesical delivery for rUTIs (Hagberg et
al., 1989). When studies using ineffective strains or testing for safety were excluded,
most studies have confirmed a reduced recurrence rate in patients receiving
Lactobacillus-containing probiotics. Individuals receiving intravaginal probiotic therapy
seemed to have a lower recurrence rate, and those who did recur did so on a longer
interval between episodes (Stapleton et al., 2011). These studies showed the importance
of maintaining good vaginal ecology for preventing rUTI. Although probiotic treatment
might generally have a slightly inferior therapeutic effect (Beerepoot et al., 2012) when
compared to traditional long-term antibiotic prophylaxis, this antimicrobial-sparing, welltolerated strategy could possibly reduce the UTI-associated costs and morbidity,
including time lost from work, health care costs, antimicrobial use, and the ultimate
development of antimicrobial resistance (Russo & Johnson, 2003). More evidence with
larger sample size and validated dosing strategies are needed to confirm the efficacy of
this approach.

1.4.5.2

Future probiotics and microbial therapies

Currently, a dilemma exists over antibiotic usage in rUTI management and the
development of alternative therapies, including probiotics. This is because many of these
alternative therapies are susceptible to antibiotic use. Besides the probiotic agents
mentioned above, several strategies have been undertaken to develop new probiotics
including developing avirulent E.coli strains, new lactobacilli and other strains. Avirulent
E.coli strains (i.e., strains few virulence markers of adhesion, specific O and K serotypes,
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hemolysin production, and resistance to serum effects) could serve as competitive
colonizers of the bladder (Hagberg et al., 1989). When instilled into the bladder, they
colonized the mucosa and may interfere with the onset of symptomatic infection.
Instillation of avirulent E. coli 83972 into the bladders successfully created a long-term,
antibiotic-resistant colonization that reduced symptomatic infection (Hull et al., 2000).
Another strain, E.coli Nissle 1917, has been verified by previous studies for its ability to
colonize the bowel, displacing gut pathogens as well as boosting the innate immune
response of the gastrointestinal tract (Henker et al., 2008). Recent in vitro studies have
observed the ability of E. coli Nissle 1917 to eradicate or out-grow ~75% of known
uropathogens, suggesting its potential of being used as a urinary probiotic.
The horizon of Lactobacillus-containing probiotics is continuously being widened.
Besides its abilities to restore the normal vaginal microbiota and prevent UTI, recent
studies reported that L.rhamnosus GR-1 was able to strengthen the immune response of
the urinary system (Karlsson et al., 2012), and that oral application of Lactobacillus
mixture on pregnant mice would reduce the risk of UTI on the newborn (Lee et al.,
2013). It is also quite possible that new strains of Lactobacillus, both natural and
genetically-modified, together with other bacterial species, could be applied for rUTI
prevention.
Even if there is a predisposition to having UPEC at sites beyond the urogenital tract, such
as the colon and rectum, probiotics and other microbiota modifying therapies may reduce
microbial carriage and subsequent reinfection risk. While extreme therapies such as fecal
transplant are becoming more common for chronic intestinal infections, such as recurrent
Clostridium difficile, such therapies will not be adopted quickly for UTI (Ettinger et al.,
2013). If more was understood about the microorganisms that naturally occupy the
bladder, their role in maintaining a homeostatic environment, immunomodulatory effects
and direct antagonistic effects on pathogens, a probiotic or “synthetic urine” treatment to
restore the “healthy” bladder microbiota might exist.
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1.5 The urinary microbiota: the uncultivable side
Urine was once considered sterile and only contained bacteria during infection. For
most clinicians, the presence of bacteria in urine is a pathological condition with its
severity varying from a mild asymptomatic bacteriuria to a lethal urosepsis. Such ideas
are formed due to the fact that culture-based techniques remain as the “gold standard” for
microbial pathogen detection for clinical practice. However, recent studies have shown
that although commonly used methods for clinical sample culture are effective at
detecting fast-growing pathogenic bacteria, it will neglect some slow-growing, fastidious
commensal microbial species for which their role in disease prevention and homeostasis
has not yet been determined. With the introduction of high-throughput DNA sequencebased techniques, several studies have identified evidence of commensal microbial
communities in the urinary bladder, especially in female populations. Wolfe et al. was the
first reported evidence of uncultivated bacteria in the urinary bladder (Wolfe et al., 2012).
Since then, multiple studies have investigated the urinary microbial communities using
sequencing-based techniques among various populations, as demonstrated in Table 4.
Guided by the sequencing results, enhanced culture methods based on increased sample
volume, extended culture time, a wide spectrum of media and atmospheric conditions
were developed that could isolate and identify many urinary microorganisms that
traditional culture does not (Hilt et al., 2014). Although still preliminary, these studies
have shown that the urinary microbiota significantly differs between male and females,
with the female microbiota containing higher abundance and greater diversity, which was
undoubtedly associated with microbial ascension from the lower genital tract (Wolfe &
Brubaker, 2015). These discoveries have drawn interest in exploring the association of
urinary microbiota with several urinary conditions
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Table 4. published studies characterizing the urine microbiota in human
populations
Study

Patient Demographics

Sample Collection
Method

Nelson et al., 2010

Males with STI (n=10)

First-void urine

Males negative for STI (n=9)
Dong et al., 2011

Males with STI (n=10)

First-void urine

Males negative for STI (n=22)
Siddiqui et al., 2011 (

Healthy females (n=8)

Clean-catch midstream
urine

Fouts et al., 2012

Healthy controls (n=26;

Midstream urine,

females=58%)

Intermittent

Neurogenic bladder patients

Catheterization, Foley

(n=27, female=48%)

Catheter

Nelson et al., 2012

Healthy adolescent males (n=18)

First-void urine

Siddiqui et al., 2012

Females with IC (n=8)

Clean-catch midstream
urine

Wolfe et al., 2012

Healthy females (n=12)

Clean-catch midstream

Females with pelvic organ

urine, suprapubic aspirate,
transurethral catheter
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prolapse or urinary incontinence
(n=11)
Lewis et al., 2013

Fricke et al., 2014

Healthy males (n=6)

Clean-catch midstream

Healthy females (n=10)

urine

First renal transplant patients

Not described

(n=60; females=37%)
Hilt et al., 2014

Healthy females (n=24)

Transurethral

Females with overactive bladder

catheterization

(n=41)
Pearce et al., 2014

Healthy females (n=58)

Transurethral

Females with urgency urinary

catheterization

incontinence (n=60)
Willner et al., 2014

Acute uncomplicated UTI

Midstream urine

patients (n=50; females=76%)
Horwitz et al., 2015

Aged adults with chronic urethral

Urethral catheter section

catheter (n=11, male = 82%)
Thomas-White et al., 2015

Healthy females (n=60)

Transurethral
catheterization

Females with urinary urgency
incontinence (n = 74)
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Shoskes et al., 2016

Chronic Prostatitis/Chronic Pelvic Midstream urine
Pain Syndrome patients (n=25)
Healthy males (n=25)

Karstens et al., 2016

Female urinary urgency

Transurethral

incontinence patients (n=10)

catheterization

Healthy females (n=10)
Modena et al., 2017

Renal transplantation patients

Midstream urine

(n=25)
Healthy individuals (n=20, males
= 50%)
Groah et al., 2016

Neuropathic bladder patients

Midstream urine

(n=24)
Healthy controls (n=23)
Rani et al., 2016

Renal transplantation patients

Midstream urine

(n=21)
Healthy controls (n=8)
Gottschick et al., 2017

Women with BV/receiving
treatment (n=109/43)

Midstream urine
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Healthy controls (n=80
male=39%)
Shrestha et al., 2017

Prostate cancer patients (n=65)

Midstream urine

Males with benign prostate
(n=65)

1.6 Common urinary conditions and their association with
the urinary microbiota
Multiple studies have suggested that the human urinary microbiota may contribute to
symptoms or pathogenesis of many urinary conditions. As initially reported by Wolfe et
al., the commensal urinary microbiota can be detected by both sequencing-based and
enhanced culture methods (Hilt et al., 2014, Wolfe et al., 2012), and are clearly different
form contaminating microorganisms and pathogens causing UTI (Nienhouse et al., 2014,
Siddiqui et al., 2011). Pearce et al. examined the urinary microbiota of females with
urgency urinary incontinence and found several bacterial species more common in the
diseased state than in healthy controls, including Actinobaculum, Actinomyces,
Aerococcus, Arthrobacter, Corynebacterium, Gardnerella, Oligella, Staphylococcus,
Streptococcus and L.gasseri (Pearce et al., 2014). Siddiqui et al. used 454
pyrosequencing to investigate urine samples from women with interstitial cystitis and
found a remarkable increase in Lactobacillus together with decreased microbial diversity
(Siddiqui et al., 2012). Fouts et al. compared urinary microbiota pattern of patients with
spinal cord injury and found Lactobacillales, Enterobacteriales, Actinomycetales,
Bacillales, Clostridiales, Bacteroidales, Burkholderiales, Pseudomonadales,
Bifidobacteriales, and Coriobacteriales to be the most abundant bacterial taxa (Fouts et
al., 2012).
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1.7 Questions and challenges associated with studying the
microbiota of the urinary tract
1.7.1 Common questions of urinary microbiota studies
1.7.1.1

What do they do in the urinary tract?

The urinary microbiota shares some similarities with microbiota of the lower genitalia,
but with a lower abundance. Questions have been raised about the function of these
commensal urinary microbes. In the lower urogenital tract, such as the vagina, it is
known that certain bacteria act as sentinels and protectors against potentially dangerous
microorganisms that may ascend further and cause an infection, such as UTI (Beerepoot
et al., 2012; Beerepoot et al., 2016). It is not known if or how the microbiota may play a
protective role in the bladder, but it is assumed that the lower urogenital tract is the
gateway to this region. Studies demonstrating probiotic treatment to the urogenital tract
reduces UTI recurrence rates supports this idea (Beerepoot et al., 2016). The numbers of
commensal bacteria in the bladder are thought to be considerably less than the lower
genital tract, and several remain to be cultured(Whiteside et al., 2015). Even though
bacterial numbers are lower in this region, they still have the potential to out-compete
pathogens for necessary nutrients, produce antimicrobial substances and stimulate the
immune system.
Where bacteria colonize other human surfaces, they play a key role in the homeostasis of
the mucosal environment and numerous studies detail these on skin, buccal cavity, nasal,
small intestine, bowel, lung and vaginal interactions (Cosseau et al., 2008; Dickson et al.,
2015; Hummelen et al., 2011; Lopetuso et al., 2014; Pfefferle & Renz, 2014; SanMiguel
& Grice, 2015). It makes sense to presume that even while there may be fewer bacteria in
the urinary system than many other colonized sites, these microorganisms still play a
significant role in the maintenance of the uroepithelium.

1.7.2 Is the urinary microbiota associated with urinary malignancy?
The theory of inflammation causing bladder cancer dates back to Virchow’s report in
1860 (Virchow & Chance, 1860) and presently remains under controversy. Multiple
epidemiological studies have looked at the association between UTI and bladder cancer
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yielding conflicting results (Abol-Enein et al., 2008; Hartge et al., 1990; Kantor et al.,
1984; Kjaer et al., 1989; Pelucchi et al., 2006; Pisani et al., 1997). It is understandable
since most studies have relatively small sample size, and had a cross-sectional or
retrospective design. Vermeulen et al. investigated 1809 bladder cancer patients and
compared their data to 4370 control participants. The results showed that regular cystitis
is a contributing risk factor for bladder cancer, and this risk may be alleviated by
receiving antibiotics for UTI treatment (Vermeulen et al., 2014). It is with the hope that
the introduction of meta-omics techniques could shed further light on this mystery.

1.7.2.1

How far up the urinary tract do bacteria go and how
commonly are they found in the kidney?

While urine passes from the kidney through the urological system to exit in the external
environment, the kidney is not typically considered to be routinely occupied by bacteria.
Under pathological conditions such a severe UTI or urine reflux, bacteria may invade the
kidney by an ascending route causing pyelonephritis, pyonephrosis, and urosepsis.
Urinary stasis caused by obstructions of the upper urinary tract also predisposes the
kidney to bacterial infection. However, in case of upper urinary obstruction such a stone
in the upper ureter, there are no factors promoting bacterial ascending, making it difficult
to explain the source of bacteria in the kidney with current theories. In preliminary
studies looking at the microbiota within kidney stones, it appears that bacteria can be
detected both by culture and non-culture microbiological techniques (Barr-Beare et al.,
2015). Interestingly, preliminary data of five pediatric subjects suggests that bacteria may
be detected as far as the kidneys and may be present within the kidney stones themselves.
The nidus for kidney stone formation and precipitation from urinary supersaturation is
thought to be inflammation. The potential for bacteria to cause this is one possibility and
in murine studies, it was shown that the presence of calcium oxalate deposits increases
pyelonephritis risk, likely due to preferential aggregation of bacteria on and around
calcium oxalate crystals (Barr-Beare et al., 2015).
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1.8 Microbiota investigations of human tissue with low
microbial biomass
While the urological system has been shown to have bacteria within it, these bacteria are
in relatively small numbers compared to other sites occupied by bacteria in the human
body (Lewis et al., 2013). The processing and handling of samples with low microbial
biomass are much more challenging than conventional microbe-rich samples as the
sequencing results can be overshadowed by “noise” reducing the reliability when
studying a microbiota of interest. Reagent contamination is a known issue for molecular
biology experiments (Champlot et al., 2010; Shen et al., 2006), it is also recognized in
metagenomics studies (Glassing et al., 2016). In 2014, Salter et al. showed a serially
diluted pure culture of Salmonella bongori samples then subjected to DNA extraction,
16S rRNA gene amplification and sequencing yields growing the proportion of
background noise in sequencing reads as the dilution proceeds. The number of PCR
cycles also affected sequencing quality. For samples with low microbial biomass, 20
cycles were too low to generate sufficient amplicons while 40 cycles generated too much
noise (Salter et al., 2014). The optimal PCR cycle number may need to be optimized for
each sample type or batch of samples. On the other hand, Kennedy and colleagues
showed that the template concentration in samples, i.e., the input microbial biomass, also
affected sequencing quality, weakening the microbial vs. background ratio (Kennedy et
al., 2014). Since then, multiple studies have confirmed the existence of inherent bacterial
DNA in reagents and environment, contributing contaminating microbes to a total
number of 181 genera (Glassing et al., 2016; Shen et al., 2006; Weiss et al., 2014). The
term “kitome” or “contaminome” was then introduced to describe these contaminating
reagent microbial DNA (Dickson et al., 2017; Kverka et al., 2017). The kitome differs by
manufacturer and model, kit batch, and even in different tubes or lots of one product
(Glassing et al., 2016; Weiss et al., 2014). Therefore, it is crucial to process all samples
in a project in a short period, preferably using one kit if possible. Recording the type of
kit used, together with its batch number is strongly recommended. In case multiple kits
were required to be used, it should be taken into the potential confounding factors for
statistical analysis.
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In this thesis, another confounding factor was analyzed. The host DNA that is present in
the sample may affect sequencing results, especially in case of samples with high host-,
low microbial biomass (“high-low samples”). When quality-checking samples, the host
DNA abundance should also be taken into consideration, rather than only evaluate the
microbial vs. background/reagent ratio as most previously published article has done.
This analysis will be further discussed as a major component of the second chapter.

1.9 Scope and objectives of the thesis
In this thesis, the microbiota of the human urinary tract was investigated. Multiple trials
were conducted to collect various clinical sample including urine and surgical tissue
samples from the urinary system. There are a limited number of studies looking at the
urinary microbiota, and at the onset, none have analyzed their sample handling
techniques and potential confounding factors. To our knowledge, there is no published
data of microbiota of renal tissue, and urine of stone and bladder cancer patients. The
general hypothesis is that a dynamic microbiota exists in the urinary tract and these
microbial shifts exhibit different phenotype across various urinary conditions. Since the
method of studying the urinary microbiota has yet to be standardized, this was the first
step to develop and optimize algorithms for urinary tissue microbiota and urine
microbiota. This methodology was used in Chapter 2, 3, 4 to handle “high-low” samples.
Samples with low microbial biomass are recently reported to be vulnerable to reagent
contaminations, and in Chapter 2 this was further examined to show that the presence of
host DNA could exert negative effects on sequencing results on multiple levels. A refined
protocol was developed and utilized in renal microbiota profiling in a later section of
Chapter 2. In chapter 3, we focused on characterizing the urinary microbiota of a healthy
individual and urinary stone patients and investigated the stability of urinary microbiota
by analyzing several temporally discrete samples from the same donor. In Chapter 4, we
observed fluctuations of urinary microbiota during lithotripsy surgeries in urinary stone
patients to examine the possible existence of bacteria in metabolic urinary stones.
Overall, these studies constitute a comprehensive picture of the urinary microbiota in
various conditions. The following studies have generated multiple methods and
techniques for microbiota research in sites without a rich microbial community. The
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importance of understanding the potential pitfalls of microbiota research is underscored,
and this thesis will provide further insight into future techniques of carrying out such
studies.
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Chapter 2

2

Optimization of methodology of handling samples of
high host and low microbial biomass reveals the renal
microbiota

2.1 Introduction
Through culture-independent microbial identification protocols, microbiota studies have
demonstrated that a rich and diverse microbial community inhabits in the human body,
varying in its structure, abundance and function depending on body sites (Costello et al.,
2009; Ding & Schloss, 2014; Segal & Blaser, 2014). The microbes inhabiting these sites
have been found to play critical roles in maintaining the normal function of host
metabolism (Bäckhed et al., 2004), hormone regulation (Markle et al., 2013) and even
psychological status (Hsiao et al., 2013). Additionally, certain microbiota profiles have
also been associated with numerous conditions including diabetes mellitus, inflammatory
bowel diseases, and multiple sclerosis. (Berer et al., 2011).
As the exploration of microbiota-associated diseases continues, a growing number of
studies have been carried out to investigate the microbiota in sites with comparatively
low microbial abundance. These include the brain (Branton et al., 2013), breast
(Urbaniak et al., 2014), atherosclerotic plaques (Koren et al., 2011), placenta (Aagaard et
al., 2014), blood (Potgieter et al., 2015) and from an important urological perspective, the
bladder (Wolfe et al., 2012). Detection of bacterial DNA sequences in these sites
questions the concept of sterility, and the role of bacteria within the body. However,
before drawing such conclusions, sampling bias, DNA contamination, and accuracy of
microbiota data analysis must be addressed.
The first definitive description of the bladder microbiota was only undertaken relatively
recently, by the direct collection of urine aspirated supra-pubically in an attempt to
discount urogenital contamination of specimens (Wolfe et al., 2012). This discovery
challenged the dogma that the urinary tract is sterile. Several other studies also confirmed
an existant microbiota in the bladder and associated it with various conditions including
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incontinence, interstitial cystitis and neurogenic bladder (Pearce et al., 2014; Siddiqui et
al., 2012; Groah et al., 2016). Although the exact association of the urinary microbiota of
these conditions remains to be elucidated, it has gradually come to people’s awareness
that a viable urinary microbiota, although unable to be detect by routine culture methods,
exist in the bladder.
However, whether microorganisms exist in the upper urinary tract remains unclear. To
date, there’s no study looking specifically at urinary microbiota of the upper urinary tract
in asymptomatic individuals without infective conditions. However, the ascension of
bacteria through the urinary tract beyond the bladder causing infections such as
pyelonephritis have also been commonly reported (Andersen & Jackson, 1961),
suggesting the possibility of bladder microbiota ascending to the upper urinary tract. On
the other hand, asymptomatic infections do occur in the upper urinary tract (Dontas et al.,
1981; Kass et al., 1972), which could be originated from the microbiota of the upper
urinary tract among asymptomatic individuals.
Applying the novel sequencing-based techniques to the study of urinary microbiota is not
without difficulties. One of the technical challenges of studying the microbiota of the
upper urinary tract is sample collection. It is difficult to obtain kidney samples for
microbiota analysis due to the invasiveness of procedures. This is especially true for
obtaining samples from healthy individuals. The use of renal tumour and “healthy”
adjacent tissue samples offers the opportunity to examine the microbiota without added
morbidity to the patient. Samples of tissue are excised during nephrectomy. This setting
also allows for comparison of the microbiota of tumour and healthy renal tissue.
Another technical challenge is the sample handling. Given that renal tissue samples have
much lower microbial abundance, sample processing and analysis protocols taken
directly from gut microbiota studies have not been properly validated. Problems not
considered are relating to factors which are associated with the high proportion of host
DNA that is present in the sample must be taken into consideration.
In this study, protocols were developed for analyzing low microbial abundance samples
in tissue. These protocols were optimized and compared to standard protocols. The aim
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was to determine whether renal tissues had a detectable microbiota and if it was different
within tumours compared to healthy tissue sites.

2.2 Methods
2.2.1 Cell lines and bacterial strains
Transitional cell carcinoma-derived human 5637 cells were obtained from the American
Type Culture Collection (ATCC® HTB-9™, Manassas, VA, USA). Cells were cultured in
RPMI-1640 with 10% fetal bovine serum plus 2 mM glutamine. E. coli DH5α cells were
maintained on Luria-Bertani (LB) medium containing 1.5% agar (LB agar). When
required, a single isolated colony was transferred into LB medium and grown overnight
at 37℃ on LB with continuous shaking. Gardnerella vaginalis (ATCC® 14018™) was
maintained on Columbia blood agar (CBA) containing 5% sheep blood. When required, a
single isolated colony was transferred into Brain Heart Infusion (BHI) broth and was
grown overnight at 37℃ with continuous shaking.

2.2.2 Sample collection
Biological materials, including paired tumour and control “healthy-adjacent” tissue
samples from fifty-six donors, were provided by the Ontario Tumour Bank, which is
funded by the Ontario Institute for Cancer Research. Ethical approval for the study was
granted by the University of Western Ontario Human Ethics Committee and Lawson
Health Research Institute (protocol number HSREB 104309). The samples included
tumour tissue and a control specimen consisting of an adjacent non-tumorous tissue,
approximately 4 cm away from the tumour. Tumor samples represent various grades and
pathologies, as shown in the appendix. Sample size varied from approximately 0.2 to 1
cm3. These were aseptically transferred into cryogenic vials and stored at -80°C until
further analysis.
To collect bacterial samples from the exterior of the tumour tissue, the entire tissue mass
was transferred to a 2 ml microcentrifuge tube containing 1 ml DNA-free phosphatebuffered saline (PBS, pH 8.0). The samples were placed in a sonicating water bath
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(Branson® Ultrasonic Bath Model 1200) at 60 Hz for 5 minutes then vigorously for 1
minute. The remaining liquid was enriched for any bacteria present on the surface. These
samples underwent the standard DNA extraction protocol developed for the other tissue
samples.

2.2.3 Tissue surface decontamination and fragmentation
Specimens were aseptically transferred to 20 ml of DNA-free PBS and vortexed for 20
sec. The PBS was removed, and 20 ml of DNA-free 75% ethanol was added for 3
minutes, followed by 20 ml of 5% bleach for 1 min, 75% ethanol for 2 min and finally
five wash cycles of DNA-free PBS. The samples were then centrifuged, discarding the
supernatant and then homogenised using a DNA-free microtube and pestle (KimbleChase Kontes™ Pellet Pestle™, Fisher Scientific). PBS was then added a final
concentration of 0.4g tissue/ml. The tissue lysate, together with all the surface control
samples, were used for routine culture, EQUC and DNA extraction for 16S rRNA gene
sequencing. Five reagent controls were taken during the experiment (including PBS,
water, DNA-extraction and PCR amplification reagents). Samples were stored at -80℃
until further analysis.

2.2.4 DNA extraction
When required, tissue homogenates were thawed on ice, and the DNA was extracted.
Tissue was homogenized using the manufacteurer’s protocol specific to the MOBIO
PowerSoil® 96 well Kit and Qiagen QIAamp kit. For the refined protocol, ethanol
precipitation was applied instead of the conventional filter binding protocol.

2.2.5 gDNA copy number estimation
In pure culture samples, the gDNA copy number was estimated by Qbitz (Qiagen,
Mississauga, ON, Canada) and nanodrop (Thermo Scientific). For mixed samples the
E.coli DH5a gDNA copy number was estimated by qPCR quantification. To ensure the
accuracy of qPCR quantification NEBnext® Microbiome DNA Enrichment Kit (New
England Biolabs, Beverly, MA, USA)was used to remove host DNA and enrich E.coli
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DNA. The DNA samples were then serially diluted to confirm an optimal Ct value to
avoid potential inhibition.of amplification

2.2.6 PCR amplification
Extracted DNA from the clinical samples were PCR-amplified with barcoded primers as
described by Gloor et al. (2010) shown in Appendix A. The PCR was performed in a 42μl reaction system, with details listed in Appendix B. Following PCR, the amplicons
were quantified with the Qubit 2.0 fluorometer (Invitrogen, CA, USA). Equimolar
amounts of each amplicon were aliquoted into a single tube purified with the QIAquick
purification kit (Qiagen, Mississauga, ON, Canada). Each product was then pooled and
sequenced on the Illumina Mi-Seq platform in a paired-end run using a 600 cycle kit with
a paired-end 220-bp run at the London Regional Genomics Center (Robarts Research
Institute, London, ON, Canada), following standard operating procedures.

2.2.7 Sequence processing and taxonomic assignment.
Description of the processing algorithm has been previously published (Gloor et al.,
2010). The SOP and related software are accessible at
http://github.com/ggloor/miseq_bin. The sequences were processed following algorithm
as stated in Appendix C. Paired-end reads were overlapped with Pandaseq V2.5 (Masella
et al., 2012), allowing no ambiguous positions in the overlapped reads. Reads were then
demultiplexed and tagged with the name corresponding to the sample identifier and
barcode. After demultiplexing, reads from all samples were merged into one single file
and were clustered into individual sequence units (ISUs), which were then further
grouped into operational taxonomic units (OTUs) with open reference OTU picking
method, using Uclust algorithm of USEARCH version 7, which has a de novo chimera
filtering step built into it (Edgar et al., 2010; Edgar et al., 2015). The identity threshold
was 97%. Singleton OTUs and ones with abundance < 1% were discarded. Taxonomical
assignment was performed with mothur 1.3.4 to annotate the OTU sequences against the
Silva database (v119).
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2.2.8 Data analysis
For data exploration, OTUs with a zero value was replaced by a small numerical value
with the count zero multiplicative methods in the zCompositions package (PalareaAlbaladejo et al., 2015). Custom R codes were generated to perform centered log ratio
(clr) transform of the zero-replaced data set. Then a singular value decomposition (SVD)
was applied to the data. The output was used for PCA plots exploration. 128 Dirichlet
Monte-Carlo (DMC) instances from the data with clr-transform were used for
quantitative data analysis. ALDEx 2 V.1.6.0 package were used for differential
abundance test. Significance was based on the Benjamini-Hochberg corrected P value of
the Wilcoxon rank test (significance threshold P < 0.1).

2.3 Results
2.3.1

High host cell abundance is associated with poor microbial
DNA yield and microbial community representation in
column-extracted DNA samples

DNA extraction kits typically use silica gel membranes to bind sample DNA. The MO
BIO Powersoil® kit, one of the most widely used DNA extraction kits for microbiota
analysis, was tested for the maximal DNA yield of E. coli DH5α cells in the presence of
human bladder 5637 cells. The Powersoil® kit and subsequent detection of bacterial DNA
via qPCR allowed for more than 109 copies of E.coli gDNA to be detected when 1010
copies of E.coli gDNA was inputted. However, 1010 copies of bladder 5637 cells would
only generate around 106 copies gDNA in the product. (Figure 2a). A similar
phenomenon was observed when Qiagen QIAamp® DNA Stool Mini Kit, another
common kit used for bacterial genomic extraction, and where DNA was inputted instead
of cells for both extraction kits (Figure 3a, 4a, and 5a). When a mock sample of mixed E.
coli DH5α cells and bladder 5637 cells went through DNA extraction, the microbial
gDNA yield of the mock sample started to drop when bladder 5637 cell number exceeded
104, (Figure 2b, 3b, 4b, and 5b). However, when the final kit collection steps involving
the silicon-embedded filters were substituted for ethanol precipitation, the “column

64

saturation effect” of the 5637 cell DNA yield was reduced (Figure 2c, 3c, 4c and 5c), and
a higher microbial DNA detection/ recovery was observed from the mixed mock samples
(Figure 2d, 3d, 4d and 5d). It appears that column-based DNA extraction methods have
poorer microbial DNA yields in the presence of highly abundant host DNA reducing the
sensitivity of its detection.
To investigate if the microbial DNA recovery rate is associated with microbial sampling
bias and poorer microbiota representation, “mock” or simulated community samples with
six bacterial strains were combined with increasing numbers of bladder 5637 cells. These
samples were then DNA-extracted with the Powersoil® kit. Extracted DNA was then
amplified with primers specific for the V4 region of the 16S rRNA gene and sequenced.
Analysis demonstrated that in mock samples starting with equal numbers of each
bacterial type, when the host gDNA present exceeds 105 copy/sample, the bacterial
community representation was severely compromised (Figure 6). In summary, silicon
columns-based DNA extraction methods have a limited DNA yield and may compromise
microbial DNA yield with abundant host DNA in the sample.

2.3.2

Effect of background DNA on microbial DNA amplification
and sequencing analysis

Background DNA from host tissue could be another factor which potentially hampers the
PCR amplification and quality of downstream analysis. To look at the impact of this, a
series of extractions containing increasing concentrations of bladder 5637 gDNA with a
constant amount of E. coli DH5α gDNA was created. The bacterial gDNA copy was then
estimated with qPCR. The results indicated that the amplification efficiency started to
decrease when 103 copies of 5637 bladder cell gDNA were present and became severely
inhibited above 3.5 x105 copies (Figure 7a). Dilution of sample concentration could help
mitigate the inhibitory effect, as shown in Figure 7b, where when a mock sample with
109 copies of E. coli gDNA and 105 copies of bladder 5637 gDNA receive a hundred-fold
dilution, the Ct difference to the mock sample with same microbial biomass but no
bladder gDNA dropped from 3.12 (12.57 vs 9.45) to 0.06 (15.72 to 15.66). Similarly, a
100-fold dilution of a mock sample with 107 copies of E. coli gDNA and 105 copies of
bladder 5637 gDNA reduces the Ct difference from 4.46 (20.12 vs 15.66) to 0.64 (23.49
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vs 22.85) (Figure 7b). When observing the 16S rRNA gene sequencing results with mock
microbial samples combined with 5637 bladder cell gDNA, the microbial composition
becomes proportionally distorted with higher the background DNA present. This
distortion occurred when DNA abundance was under 105 copies/ ml in the template, or
when host gDNA concentration was 1000 times higher in copy numbers than microbial
gDNA (Figure 7c and 7d). To mitigate inhibitory effects of host DNA during the PCR.
We tried to use a commercial host DNA removal kit (NEBnext® Microbiome DNA
enrichment Kit) to remove host DNA. However, the host DNA remained, especially in
conditions where a high amount of host DNA was present (Figure 8 and 9a).

Figure 2 Effect of host cells in the sample on microbial DNA yield. In this plot, E.coli
DH5a cells or bladder 5637 cells (for a and c) or their mixtures (for b and d) at various
amounts received DNA extraction with MO BIO Powersoil® kit standard protocol (for a
and b) or adapted protocol, with the last collection steps involving the silicon-embedded
filters were substituted by ethanol precipitation (for c and d). X-axis shows sample cell
number, Y-axis shows estimated DNA copy number after DNA extraction with qPCR
(for E.coli DH5a cells) or DNA fluorometer and spectrophotometer (for bladder 5637
cells). (a) DNA yield of E.coli DH5a cells (Red) and bladder 5637 cells (Yellow) in

66

estimated copy numbers, with standard extraction protocol; (b) E.coli DH5a DNA yield
in estimated copy numbers, with standard DNA extraction protocol, from mixture
samples of E.coli DH5a cells or bladder 5637 cells; (c) DNA yield of E.coli DH5a cells
(Red) and bladder 5637 cells (Yellow) in estimated copy numbers, with adapted
extraction protocol; (d) E.coli DH5a DNA yield in estimated copy numbers, with adapted
DNA extraction protocol, from mixture samples of E.coli DH5a cells or bladder 5637
cells.

Figure 3 Effect of host cells in the sample on microbial DNA yield. In this plot, pure
cultures of E.coli DH5a cells or bladder 5637 cells (for a and c) or their mixtures (for b
and d) at various amounts received DNA extraction with Qiagen QIAamp® DNA Stool
Mini Kit standard protocol (for a and b) or adapted protocol, with the last collection steps
involving the silicon-embedded filters were substituted by ethanol precipitation (for c and
d). The x-axis shows sample cell number; Y-axis shows estimated DNA copy number
after DNA extraction with qPCR (for E.coli DH5a cells) or DNA fluorometer and
spectrophotometer (for bladder 5637 cells). (a) DNA yield of E.coli DH5a cells (Red)
and bladder 5637 cells (Yellow) in estimated copy numbers, with standard extraction
protocol; (b) E.coli DH5a DNA yield in estimated copy numbers, with standard DNA
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extraction protocol, from mixture samples of E.coli DH5a cells or bladder 5637 cells; (c)
DNA yield of E.coli DH5a cells (Red) and bladder 5637 cells (Yellow) in estimated copy
numbers, with adapted extraction protocol; (d) E.coli DH5a DNA yield in estimated copy
numbers, with adapted DNA extraction protocol, from mixture samples of E.coli DH5a
cells or bladder 5637 cells.

Figure 4 Effect of host DNA in the sample on microbial DNA yield. In this plot, E.coli
DH5a DNA or bladder 5637 DNA samples (for a and c) or their mixtures (for b and d) at
various copies where input into the DNA-binding column of MO BIO Powersoil® kit and
went through its standard protocol (for a and b) or adapted protocol, with the last
collection steps involving the silicon-embedded filters were substituted by ethanol
precipitation (for c&d). X-axis shows sample cell number, Y-axis shows estimated DNA
copy number after DNA extraction with qPCR (for E.coli DH5a cells) or DNA
fluorometer and spectrophotometer (for bladder 5637 cells). (a) DNA yield of E.coli
DH5a DNA (Red) and bladder 5637 DNA (Yellow) in estimated copy numbers, with
standard extraction protocol; (b) E.coli DH5a DNA yield in estimated copy numbers,
with standard DNA extraction protocol, from mixture samples of E.coli DH5a DNA or
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bladder 5637 DNA; (c) DNA yield of E.coli DH5a DNA (Red) and bladder 5637 DNA
(Yellow) in estimated copy numbers, with adapted extraction protocol; (d) E.coli DH5a
DNA yield in estimated copy numbers, with adapted DNA extraction protocol, from
mixture samples of E.coli DH5a DNA or bladder 5637 DNA.

Figure 5 Effect of host DNA in the sample on microbial DNA yield. In this plot, E.coli
DH5a DNA or bladder 5637 DNA samples (for a and c) or their mixtures (for b and d) at
various copies where input into the DNA-binding column of Qiagen QIAamp® DNA
Stool Mini Kit and went through its standard protocol (for a and b) or adapted protocol,
with the last collection steps involving the silicon-embedded filters substituted by ethanol
precipitation (for c&d). The x-axis shows sample cell number; Y-axis shows estimated
DNA copy number after DNA extraction with qPCR (for E.coli DH5a cells) or DNA
fluorometer and spectrophotometer (for bladder 5637 cells). (a) DNA yield of E.coli
DH5a DNA (Red) and bladder 5637 DNA (Yellow) in estimated copy numbers, with
standard extraction protocol; (b) E.coli DH5a DNA yield in estimated copy numbers,
with standard DNA extraction protocol, from mixture samples of E.coli DH5a DNA or
bladder 5637 DNA; (c) DNA yield of E.coli DH5a DNA (Red) and bladder 5637 DNA
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(Yellow) in estimated copy numbers, with adapted extraction protocol; (d) E.coli DH5a
DNA yield in estimated copy numbers, with adapted DNA extraction protocol, from
mixture samples of E.coli DH5a DNA or bladder 5637 DNA.

Figure 6 Effect of host DNA on 16s rRNA gene sequencing. Stacked bar plot showed
percentage relative abundance of microbial species (n = 6) in even mock samples from
16s rRNA gene sequencing. Each column stands for a mock sample. Mock samples are
made with mixtures of six bacterial culture at even amount. Samples are sent in triplicates
for sequencing. For each plot, the first column on the left demonstrates the composition
of the input microbial mock sample. The next nine columns showed sequencing results of
three sets of samples in triplicates, with each set of microbial mock sample spiked with
no bladder 5637 cells, 103 5637 cells, 105 5637 cells respectively. Samples in this plot
were DNA-extracted with MO BIO Powersoil® kit standard protocol (for d,e, and f ) or
adapted protocol, with the final kit collection steps involving the silicon-embedded filters
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were substituted by ethanol precipitation. (a) Mock samples with the estimated cell
number of 109 and DNA-extracted with the adapted protocol. (b) Mock sample with the
estimated cell number of 107 and DNA-extracted with the adapted protocol. (c) Mock
sample with the estimated cell number of 105 and DNA-extracted with the adapted
protocol. (d) Mock sample with the estimated cell number of 109 and DNA-extracted
with the standard protocol. (e) Mock sample with the estimated cell number of 107 and
DNA-extracted with the standard protocol. (f) Mock sample with the estimated cell
number of 105 and DNA-extracted with the standard protocol.
Another issue associated with high host DNA abundance during PCR is the amplification
of non-specific DNA by the 16S rRNA gene-targeted primers. Several primer sets based
within conservative regions but designed to amplify adjacent V1-V3, V3-V4, V4 and V8V9 variable regions have been reported to non-specifically amplify human DNA. In our
study, isolated gDNA of renal tissue samples was amplified with V4 primers, agarose gel
electrophoresis of the amplification product demonstrated two bands at 385 kb and 302
kb, which confirmed non-specific amplification (Figure 9a and 10). Non-specific
amplification products can reach high abundance and potentially consume a significant
proportion of a next generation sequencing run (Figure 9b). A commercial microbial
DNA enrichment kit tested, was not able to fully mitigate the non-targeted amplification
when human DNA was present in abundance (Figure 9c and 9d). In our experience,
different primers have different amplification specificity on different samples types
(Figure 11). Thus, a pilot study to test the amplification performance of a given primersample combination maybe necessary before the main study starts.

2.3.3

Investigating renal tumor tissue microbiota: simple protocol
vs. refined protocol

Using the refined protocol for human tissue microbiota investigation, we extracted and
analyzed 56 renal cell carcinoma tissue samples and their adjacent pairs in non-tumour
tissue. The mass and qPCR-estimated microbial abundance is presented in supplement
file. DNA samples were PCR-amplified using the V4 16S rRNA gene region primers and
sent for high throughput sequencing. An exploratory biplot (Figure 15a) shows that the
“simple” protocol, as typically used for other microbiota studies (e.g., faecal material),
utilizing column-based DNA extraction kits resembles that of the reagent control (no
significant OTUs between the two group, using ALDEx2), suggesting sparse microbial
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existence. However, when the samples were estimated of their microbial and host gDNA
abundance with qPCR, DNA fluorometer and spectrophotometer, triaged according to
their quality and processed through the refined algorithm,
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Figure 7. Influence of non-target DNA upon the performance of PCR amplification and subsequent
sequencing results. (a) Ct values of quantitative PCR to detect E.coli DH5a DNA were shown in the line
plot. Mock samples were made of serially diluted E.coli DH5a DNA solution spiked with none, 103 copy
and a 3.5x105 copy of bladder 5637 cell DNA. (b) Ct values of quantitative PCR to detect E.coli DH5a DNA
were shown in the line plot. Mock samples were made of serially diluted bladder 5637 cell DNA solution
spiked with 105 copy, 107copy and 109copy of E.coli DH5a DNA. Colored circles show changes of ct value
of a 100-fold dilution 109 to 107 copy of E.coli DH5a DNA (red circles) or 107 to105 copy of E.coli DH5a
DNA (blue circles). The inhibiting effect is alleviated after dilution. (c) Stacked bar plot showing results of
percentage relative abundance of microbial species (n = 6) in even mock samples from 16s rRNA gene
sequencing. Each column stands for a mock sample. Mock samples are made with mixtures of six bacterial
culture with estimated 106 gDNA copy number. Samples are sent in triplicates for sequencing. The left most
bars demonstrated the composition of the input microbial mock sample. The next three columns were
sequencing results of reagent control. Each set of mock samples were spiked with bladder 5637 cell DNA at
various concentration. (d) Compositional biplot of the same set of mock samples as described in (c). Sample
sets were colored to make them distinguishable. The arrows indicate the amount and direction of variation of
the ratio of each OTU to all others in the data set. The top and right axes indicate the values for variable
loadings, and the bottom and left axes indicate the unit sum-of-squares values of the principle components.
The proportion of variation explained by components 1 and 2 is also indicated.
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Figure 8. Host depletion effects on human vaginal samples. Bar plot shows the
proportion of sequencing reads of human origin. Four human vaginal swab samples went
thorough this experiment. Samples labelled as “no depletion” are RNA samples in a
transcriptomic experiment, while samples labelled as “depletion” are DNA samples in a
metagenomic experiment, treated with NEBnext® Microbiome enrichment Kit. These
data showed that microbial enrichment kit was unable to deplete the host component in a
sample completely.
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Figure 9. Unspecific amplification of host DNA. (a) Agarose gel electrophoresis of PCR amplification products of a few renal
samples. Besides the expected amplification product of V4 primers (385 bp, arrow) there is another band (302 bp, arrowhead), which
were confirmed to be unspecific amplifications of human DNA (refer figure s5). (b) Dot plots showing the proportion of unspecific
amplification for a batch of renal samples with low microbial abundance. Y-axis = mitochondrial% in sequencing results, x-axis =
estimated human DNA% in samples as copy number achieved by qPCR, Nanodrop, and Qubit. For microbial qPCR, if microbial
DNA below detection level then considers 100% human DNA. (c) and (d) Stacked bar plot showing proportion of unspecific host
DNA amplification from V4 primer before (c) and after (d) treatment from a commercial microbial DNA enrichment kit.
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Figure 10. BLAST alignment of V4 primer and human DNA sequences.

Figure 11. Comparison of the primer combination. A batch of selected renal tissue
samples was sent for sequencing with V4, V6 and V5V9 primers on separate sequencing
run. Here’s a few of them for demonstration. Overall V4 primers had the highest
amplification specificity.
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Figure 12. Effects of PMA treatment on live and dead microbial cells and
subsequent PCR amplification performance. (a) PMA has little impact on qPCR
quantification results of live E.coli DH5a cells, while it could deactivate the gDNA of
heat-killed E.coli DH5a cells. Primer used: V6 (refer to Methods section)

2.3.4

Refined processing for microbiota analysis of High-Low
samples.

To better handle the high-low samples, we developed a refined protocol including criteria
to exclude the low-quality samples from sequencing (Figure 14b), and processing steps to
mitigate the negative effect of host and background DNA, including surface washing,
PMA treatment and microbial DNA enrichment (Figure 13). In the quality-checking
experiment, the test samples were sent for 16S rRNA gene sequencing, and samples with
contaminating bacterial reads lower than 1% is marked as “very good”, 1-10% as “good”,
10-40% as “intermediate”, 40-60% as “poor” and higher than 60% as “very poor” (Figure
14a). The estimated input cell number of G. vaginalis of these samples were recorded.
After that, all samples sent for microbiota analysis will go through a quality-check
algorithm to predict their risk of sequencing results (Figure 14). Samples with microbial
abundance in “very poor” level were discarded, and the sequencing results of samples at
“intermediate” and “poor” level would go through a self-developed, refined samples
processing protocol to reduce the environmental and host DNA (Figure 12). For these
samples, the proportion of host reads was taken into consideration, where in our practice
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we set microbial reads under refined protocol > 80% as “low host proportion”, 40-80% as
“intermediate host proportion” and <40% as “high host proportion”. In mock samples
with G. vaginalis and bladder 5637 cells, we showed that the refined protocol could
mitigate the adverse effect of background noise and non-target host DNA. (Figure 14c).A
distinctive microbial consortium, different from the reagent and surface controls could be
observed (Figure 15b). A different microbial pattern was identified between the tumour
tissue group and normal adjacent tissue group, suggesting a potential different microbial
community between these two sites. On samples processed following the kit
manufacturer’s protocol, the separation was moderate, and no OTUs were detected as
being significant by ALDEx2 test (Figure 15c). On the other hand, samples that went
through the refined protocol demonstrated better separation, and 3 OTUs were detected
as significantly different between the two sites (Figure 15d). Samples with intermediate
to poor quality had better separation in the refined protocol. To confirm the sequencing
result we also performed modified expanded quantitative urine culture (EQUC) of
selected tissue samples and found that most taxonomies of the sequencing could be
recovered from the culture, including Staphylococcus, Escherichia coli,
Corynebacterium, Neisseria,Micrococcus, Sphingomonas, Weeksella, Alcaligenes, etc..
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Tissue samples

Sample washing and surface control

Tissue homogenization

PMA treatment

Ethanol precipitation-based DNA extraction

Microbial DNA enrichment kit

Primer specificity test

PCR amplification

Agarose gel electrophoresis test for PCR product

Amplification product purification

Gel extraction/ pippin-prep in case of unspecific amplification

16S gene amplicon sequencing

Expanded quantitative urine culture to confirm sequencing results

Figure 13. Refined tissue sample processing algorithm for “High-low” samples
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Figure 14. Developing a quality-checking algorithm for microbiota analysis of High-low samples. (a)
Stacked bar plot demonstrating 16S rRNA gene sequencing result of serially diluted G. Vaginalis culture
samples. Undiluted culture has about 108 cells. Each column represents a sample. As input cell number
decreases, the proportion of non-target, “noise” sequencing reads increases. Sample quality was determined
by the proportion of “noise” reads. (b) The processing algorithm for microbiota analysis of High-Low
samples. Samples with high microbial abundance usually yield decent sequencing results, and samples with
very low microbial abundance should be discarded. Samples with intermediate microbial and host DNA
proportion should go through further processing to aaaaaaaoptimise the sequencing results. (c) 16S rRNA
gene sequencing result of samples consisted of 106 cells of G. Vaginalis culture mixed with a various
amount of bladder 5637 cells. Triplicates were taken for each sample to go through PCR and 16S rRNA
sequencing. For one set of samples both routine sample processing protocols and refined sample processing
protocols were utilized and the sequencing results were compared.
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Figure 15. Compositional biplot of the renal tissue sample microbiota.
Samples were coloured to demonstrate their quality. The arrows indicate the amount and
direction of variation of the ratio of each OTU to all others in the data set. The top and
right axes indicate the values for variable loadings, and the bottom and left axes indicate
the unit sum-of-squares values of the principle components. The proportion of variation
explained by components 1 and two is also indicated. (a) Biplot of all samples. (b). Biplot
of all samples but coloured differently. Here the surface control samples were in red,
renal tissue samples that went through the refined protocol were in blue, while samples
that went through simple protocol were in green. (c) Biplot the paired renal tumour tissue
vs normal adjacent tissue samples that were processed under the simple protocol. (d)
Biplot of the paired renal tumour tissue vs normal adjacent tissue samples that were
processed under the refined protocol.
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2.4 Discussion
The 16S rRNA gene sequencing based microbial identification is one of the most
widely used methods to study human microbiota. Thanks to its culture-independent
nature, numerous previously undescribed bacterial types were found inhabiting a
human body (Lau et al., 2004; Woo et al., 2005). However, 16S rRNA gene
sequencing-based methods also have drawbacks, including multiplex-associated
biases, limited resolution at the certain species level, inability to differentiate between
bacterial DNA and viable bacterial cells (Janda & Abbott, 2007). In this study, we
showed that conventional sample processing methods derived from gut microbiota
studies were not optimal for handling low microbial, high host abundance DNA
samples. We then developed a refined protocol specifically for these sample types.
Finally, utilising this protocol, we looked at the microbial consortia from renal
carcinoma tissue and their normal adjacent counterparts.
Our results demonstrated that samples with high host eukaryotic DNA abundance and
low microbial biomass (“high-low” samples) would compromise the sequencing
results in multiple levels: firstly, the eukaryotic and prokaryotic DNA compete in
binding to the silicone filter in the DNA extraction columns typically used in
extraction kits, leading to a compromised prokaryotic DNA yield due to lack of
capacity, as is shown in Figure 2b in comparison to 2d. In our experiment, this
phenomenon was observed when both cells or free DNA was transferred into the DNA
extraction column, suggesting that it is eukaryotic DNA, not cellular components, that
compromised microbial DNA yield. Since the estimation of isolated microbial gDNA
copy number was performed with qPCR, we also used microbial DNA enrichment kit
(New England Biolabs) to deplete human DNA, and received similar results (data not
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shown) This suggests the effect is not caused by inhibitive effect of human DNA
during qPCR. In fact, commercially available DNA extraction kits can handle
common samples without issues. Taking Qiagen QIAamp® and MOBIO Powersoil®,
two of the most commonly used DNA extraction kit for gut microbiota studies for
example, the QIAamp® column has a binding capability of up to 4-12 ug per filter,
while the Powersoil® column has a binding capability of 20 ug per filter, as stated in
their user manuals. Given that most gut microbes have a genome size around 4-6 Mb,
this binding capability could retrieve presumably as high as 109 copies of bacterial
gDNA, which will indubitably have a decent representation of gut microbial
communities. However, when it comes to high-low samples, given eukaryotic cells’
much higher genome size (3000 Mb homo sapiean genome), a DNA collection filter
could only hold around 6.5x106 cells in theory. This calculation matches our results
that the bladder 5637 gDNA yield reaches a plateau at around 106 copies (Figure 2a).
Since one gram of solid tumour is estimated to have 108 to 109 tumour cells (Del
Monte et al., 2009; Rasnick et al., 2002) a common input of 200 ug tissue sample
could contain 2x107 to 2x108 cells, which could easily saturate the DNA extraction
columns. Given this and the low prokaryotic/eukaryotic gDNA ratio, the prokaryotic
DNA yield could be very low in these columns and bear the risk of poor representation
of the sample microbial community. To our knowledge, this column-associated risk
factor is not recognised in tissue microbiota studies.
Secondly, high eukaryotic DNA concentration could also affect PCRamplification of microbial DNA. In our qPCR quantification experiment, the Ct
value of 109 copies of E.coli gDNA increased from 9.4 to 18.97 with the presence of
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3.5x105 copies of bladder 5637 gDNA (Figure 7a). Although appropriate dilution of
samples mitigated the inhibitive effect (Figure 7b), when microbial biomass dropped
below 104 the sequencing result was severely biased by reagent and background DNA,
as we shown later in Figure 14a. Therefore, it is crucial to understand which sample
can have a better sequencing quality with dilution. Our quality-checking algorithm in
Figure 14b helped to solve this issue.
Thirdly, high host DNA abundance leads to unspecific amplification of commonly
used primers, consuming sequencing depths. Host DNA consuming sequencing depth
is a known issue in whole genome sequencing and RNA sequencing (Feehery et al.,
2013). Studies with whole genome shotgun sequencing in the presence of large amounts
of host eukaryotic DNA have shown that the background DNA will consume significant
amounts of sequencing depth, making sequencing inefficient, time-consuming and
inaccurate (Feehery et al., 2013). In our study, it appears that the sequencing depth of
16S rRNA gene sequencing the presence of a high predominance of host DNA is also
compromised, due to unspecific amplification of 16s rRNA gene primers. This
phenomenon was previously reported in microbiota study of blood samples and heart
valve samples (Kühn et al., 2011; Rogina et al., 2014), but to our knowledge, there’s no
report that this unspecific amplification consumes a remarkable number of reads in 16s
rRNA gene sequencing of high-low samples. Based on our results, we recommend testing
primer combinations for lowest unspecific amplification, using microbial enrichment kits
to deplete human DNA, and perform amplification product purification by agarose gel
cutting and extraction for the sample with very high host DNA abundance.
Based on these results, we then proposed that a refined protocol should be utilised when
processing high-low samples. To avoid filter competition issue, we used ethanol
precipitation as an alternative to column-binding systems to recover sample DNA and
showed that it effectively recovers DNA without reaching a “capacity ceiling”, and it did
increase microbial DNA yield in mock samples (Figure 2c and 2d). We also utilised
microbial enrichment kit to deplete eukaryotic DNA. As shown in our study, the
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enrichment kit alone is insufficient to deplete host DNA completely (Figure 8), but it did
exert positive effect when incorporated in the refined protocol (Figure 15).
In this protocol, besides issues associated with host DNA, we also seek to solve issues of
samples with low microbial biomass by identifying the lower limit of sample microbial
gDNA concentration level below which the 16S rRNA gene sequencing results will lose
its fidelity and value. We used a Gardnerella vaginalis strain to perform this qualitychecking experiment because it is commonly associated with the urinary tract and has not
been reported as a contaminant in DNA extraction kits or other reagents. In our study,
samples with a microbial abundance lower than 104/ml had >60% contamination reads
and were discarded, while samples with 10-60% contamination reads went through the
refined protocol for optimised sequencing quality. Since different labs have varying risks
to contamination due to their environment and reagent usage, an individualised lower
limit determination should be performed for each lab at least once before 16S rRNA gene
sequencing, though such quality assurance checks don’t appear to be described in the
literature.
With our developed protocol, we examined renal tumour and healthy adjacent tissue from
the same individuals for the presence of microbiota. Again, the refined protocol produced
better sequencing quality, as better separation of tissue samples from reagent controls
were observed. Many of the microbial species in the sequencing results were confirmed
by enhanced culture results, suggesting exitance of viable microbes in renal tissues.
Admittedly, conditions such as pyelonephritis typically occur where obstruction can be
present in the urogenital tract. This infection can be the result of urolithiasis and tumour.
The former has been reported in early investigations of the bacterial composition of
pediatric kidney stones which appear to show the presence of E. coli (Barr-Beare et al.,
2015).
The limitation of this study includes: the refined protocol embeds several self-developed
steps including ethanol precipitation, sample surface washing and PMA treatment etc.
since no specialised regent or materials are commercially available. These steps bear
risks of introducing contamination or decreased microbial DNA yield when not

85

appropriately handled. On the other hand, culture and sequencing-based techniques are
unable to provide direct visual evidence of bacteria in renal tissue, and therefore unable
to exclude the possibility of microbial contamination during renal tissue collection,
storage and handling.
In summary, host DNA and reagent/environmental DNA have a negative effect on
sequencing qualities of high-low samples. Our self-developed refined protocol could
mitigate some of these effects and revealed microbiota profiles in renal tissue samples.
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Chapter 3

3

Exploration and comparison of the urinary microbiota of
healthy individuals and urinary stone patients.

3.1 Introduction
Few clinical practitioners believe that the urinary tract of a healthy individual harbours a
community of viable microorganisms. The dogma during medical education is that the
presence of bacteria in urine correlates with pathological conditions such as
asymptomatic bacteriuria or urinary tract infections (UTI). The definition of these
conditions are based on one paradigm: that is urine in healthy individuals is “sterile” and
when the numbers of bacteria caught from a urine sample exceeds a given threshold
(usually 105 colony-forming units [CFU] per ml), a determination of a “positive culture
result” is made, and the patient is considered as having a pathological condition.
However, microbiologists are becoming gradually aware that traditional culture methods
favour fast-growing microbial species and ignore the slower-growing, more fastidious
commensal organisms (Pace et al., 1997). The later discoveries of intracellular bacteria in
urothelial cells and biofilms formation in urinary tract showed evidence of bacteria in
urine culture-negative individuals, and further weakened the solidity of the paradigm
(Hancock et al., 2007; Salo et al., 2009). Since the appearance of culture-independent,
sequencing-based microbial analysing methods over the past two decades from
denaturing gradient gel electrophoresis to next-generation sequencing analysis, multiple
studies have reported evidence of microorganisms in the urinary tract (Burton et al.,
2011).
Compared to other human sites occupied by bacteria, the urinary tract does not harbour
the richest habitat for microbes in the human body, which is partly the reason why it may
not have been included as a site examined in the original human microbiome project
(Consortium et al., 2012). We have shown in the previous chapter, that samples with low
microbial mass are more vulnerable to bias. This may be one of the reasons why previous
studies of urinary tract microbiota all have discrepancies between their reported urinary
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microbial community compositions. Additionally, there are no optimal sample storage
and processing methods for urine samples yet described in the literature.
Many links are now emerging between the microbiota and numerous conditions, not just
those associated with the gut microbiota and the urinary microbiota should not be
overlooked either. For example, urinary stones are among the most common urological
conditions, with 16% of the male and 8% of the female population developing at least
one symptomatic stone episode in their lifespan (Scales et al., 2012). Previously,
urologists only thought that bacteria only played a role in the formation of a certain
specified type of urinary stones, namely struvite stones, but in fact, reports have shown
that bacteria could be found in most commonly seen calcium oxalate stones (Bratell et al.
1990; Dewan et al., 1997; Gault et al., 1995; Hugosson et al. 1990; Larsen et al., 1986;
Lewi et al., 1984; McCartney et al., 1985). At present, a systemic description of urinary
microbiota patterns among urinary stone patients is still lacking. Such a description could
provide useful mechanistic and potentially diagnostic information.
In this chapter, I detail how I have optimised the methodology for urine sample
collection, storage and processing, and microbiota analysis. Then using these
methodologies, I undertook an analysis of the urinary microbiota of urinary stone
patients, comparing it to a group of age-matched, healthy individuals. I further explored
the longitudinal stability of the urinary microbiota of individuals in these two groups.

3.2 Methods
3.2.1 Evaluation of optimal storage of urine for microbiota analysis
It is well documented that the storage and handling of samples for 16S rRNA gene and
other types of NGS analysis should be undertaken in a standard manner (Di Bella et al.,
2013). Ideally, the extraction, sequencing and analysis should be done simultaneously
and therefore, the optimisation of the storage of clinical samples until this can occur is
important (Bao et al., 2017).
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To determine the optimal volume and processing for the storage of urine for microbiota
analysis, urine samples from four healthy donors were collected. The demographic
information of these four donors is shown in table 5.
Table 5. Demographic information of healthy donors for storage methods
optimization
Donor

Gender

Age

Active UTI

1

Male

28

No

2

Female

23

No

3

Female

68

No

4

Male

26

No

Urine sample collection methods are the same as the clinical urine sample collection
methods, described below in the “Sample collection” section. Each donor provided
multiple urine samples that were first pooled together then distributed into multiple forms
as described in table 6. Samples in groups A and C were centrifuged at 1000 x g for 10
minutes. The supernatant was discarded, and the pellets were stored at -80 ℃. In groups
B and D, whole urine of the desired volume was transferred to a sterile urine sample
container (Starplex, VWR) then stored in -80 ℃.

3.2.2 Clinical study design and study population
All specimens used in this study were collected, following a protocol approved by the
appropriate human ethics boards at Western University, Canada and West China
Hospital, Sichuan University, China. The participants in the stone group were patients
admitted to St. Joseph Hospital, London, ON, Canada and West China Hospital, Sichuan
University, China. Inclusion criteria were participants at least 18 years of age, nonpregnant, with no other infectious conditions, not receiving antibiotics or chemotherapy.
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The diagnosis of urinary stone was confirmed with radiological investigation, and the
patient would be scheduled to receive surgical intervention (either extracorporeal shock
wave lithotripsy (ESWL), percutaneous nephrolithotomy (PCNL) or ureteroscopy) at St.
Joseph’s Hospital. Patients were sub-grouped depending on their gender, age and location
of the stones, type of surgery they receive, chemical composition of the stone and
whether a ureteral stent is inserted. After informed consent, participants were asked to
provide two urine samples: one at the patient’s clinic visit for preoperative evaluation,
and one at the patients visit for post-operative follow up. For healthy volunteers, two
urine samples were collected with a gap of three months. All patient information was
blinded until all sample processing and DNA sequencing work were completed and only
then would the patients identified by their name initials to retrieve their grouping and
demographic information for statistical analysis.
Table 6. Urine sample collected for storage methods optimization
Groups

A

B

Volume
2ml
10ml
20ml
50ml
100ml
2ml
10ml
20ml
50ml
100ml

Forms

Storage period

Pellets

1 Month

Whole urine

1 Month

C

20ml

Pellets

D

20ml

Whole Urine

Control

2ml

Reagents

1 Month
6 Months
1 Year
2 Years
1 Month
6 Months
1 Year
2 Years
1 Month
6 Month
1 Year
2 Years
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3.2.3 Sample collection
All participants were instructed to wash their hands thoroughly with soap and water, then
to clean and wash their external genitalia with an antiseptic towelette. Urine samples
were taken with a clean-catch, midstream voided fashion: the first 10 mL was discarded,
the majority of the voided volume collected in a sterile container, and the final voided
volume was dispensed into the toilet. Once collected, all urine samples were processed
within one hour. Microbiological cultures were performed subsequently, and the
remaining of urine samples were spun down to pellets and stored at -80 ℃.

3.2.4 Microbiological culture
All collected samples were quantitatively cultured on Colombia Blood Agar with 5%
sheep blood, LB agar and MacConkey agar. Urine samples with a CFU > 105 per mL
were to be considered as active UTI and excluded. All cultivated strains were isolated
and stored. Enhanced quantitative urine culture (EQUC) was also applied following
protocols developed by Hilt et al. (Hilt et al., 2014). In brief, urine samples were cultured
with higher volume input (100ul and up to 1ml), enriched culture media (CBA, CAN
agars and thioglycolate medium), both aerobic and anaerobic culture atmosphere and
extended culture time (up to 5 days). For each morphologically unique colony on the
plate it was re-streaked into a new plate for taxonomy identification. The culture of
Ureaplasma species was following the clinical laboratory protocol adapted from ATCC
2616 Medium: basal medium [3.5 g PPLO broth, 10 g pancreatic digest of casein
(tryptone), 5 g pancreatic digest of gelatine (peptone) and 500 ml distilled water,
followed by aseptic addition of filtered sterilised solutions [50 ml 10X CMRL 1066
medium, 35 ml yeast extract solution, 20 ml yeastolate (10% w/v), 170 ml foetal bovine
serum, 20 ml 0.1% phenol red solution, 1 g urea and 205 ml distilled water.

3.2.5 DNA isolation
After storing, the samples were thawed on ice. DNA extraction was performed with
MOBIO PowerSoil® 96 well kit. In brief, lysis buffer and beads were added to urine or
urine pellets. Lysis of cells was achieved with mechanical and chemical methods. The
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suspension was then transferred to a new tube, and the subsequent procedure was
following manufacturer’s instructions.

3.2.6 16S rRNA gene library generation and sequencing
Extracted DNA from the clinical samples were PCR-amplified with barcoded primers as
described by Gloor et al. (2010) shown in Appendix A. The PCR was performed in a 42μl reaction system, with details listed in Appendix B. Following PCR, the amplicons
were quantified with the Qubit 2.0 fluorometer (Invitrogen, CA, USA). Equimolar
amounts of each amplicon were aliquoted into a single tube purified with the QIAquick
purification kit (Qiagen, Mississauga, ON, Canada). Each product was then pooled and
sequenced on the Illumina Mi-Seq platform in a paired-end run using a 600 cycle kit with
a paired-end 220-bp run at the London Regional Genomics Center (Robarts Research
Institute, London, ON, Canada), following standard operating procedures.

3.2.7 Sequencing reads processing and taxonomic assignment.
Description of the processing algorithm has been previously published (Gloor et al.,
2010). The SOP and related software are accessible at
http://github.com/ggloor/miseq_bin. The sequences were processed following algorithm
as stated in Appendix C. Paired-end reads were overlapped with Pandaseq V2.5 (Masella
et al., 2012), allowing no ambiguous positions in the overlapped reads. Reads were then
demultiplexed and tagged with the name corresponding to the sample identifier and
barcode. After demultiplexing, reads from all samples were merged into one single file
and were clustered into individual sequence units (ISUs), which were then further
grouped into operational taxonomic units (OTUs) with open reference OTU picking
method, using Uclust algorithm of USEARCH version 7, which has a de novo chimera
filtering step built into it (Edgar et al., 2010; Edgar et al., 2015). The identity threshold
was 97%. Singleton OTUs and ones with abundance < 1% were discarded. Taxonomical
assignment was performed with mothur 1.3.4 to annotate the OTU sequences against the
Silva database (v119).
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3.2.8 Bioinformatic analysis
For data exploration, OTUs with a zero value was replaced by a small numerical value
with the count zero multiplicative methods in the zCompositions package (PalareaAlbaladejo et al., 2015). Custom R codes were generated to perform centred log ratio
(clr) transform of the zero-replaced data set. Then a singular value decomposition (SVD)
was applied to the data. The output was used for PCA plots exploration. 128 Dirichlet
Monte-Carlo (DMC) instances from the data with clr-transform were used for
quantitative data analysis. ALDEx 2 V.1.6.0 package were used for differential
abundance test. Significance was based on the Benjamini-Hochberg corrected P value of
the Wilcoxon rank test (significance threshold P < 0.1).

3.2.9 qPCR estimation of 16S rRNA gene copy numbers.
The bacterial load in the urine samples were estimated by qPCR quantification of the
DNA extracts. The reaction system includes 10ul of PCR master mix, 5 ul of 800Nm
primer stock (V6 hypervariable region of 16S rRNA gene: V6-LT 5’ CCATCTCATCCCTGCGTGTCTCCGACTCAGNNNNNCWACGCGARGAACCTTA
CC3’
and V6-RT: 5’CCTCTCTATGGGCAGTCGGTGATACRACACGAGCTGACGAC 3’),
5ul of sample DNA template. A standard curve was made with known copies of E.coli
DH5a gDNA.

3.3 Results
3.3.1 Methods optimization for sample storage
We first investigated how urine samples storage/preserving techniques could affect their
sequencing qualities. Urine samples from healthy donors were either kept in pellets
(Group A) or as whole urine (Group B) for one month and then PCR-amplified with V4
primer and sent for sequencing. Among all group A samples, the ones stored at a higher
volume had greater weighted UniFrac distances to reagents, suggesting it provided a
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representation of the urinary microbiota (Figure 16). Figure 17 presents urine samples
from one donor that were either stored as whole urine or in pellets. As shown in the
PCOA plot, urine pellets had better separation from the reagents, suggesting a better
representation of the urinary microbiota. Urine samples with higher volumes generally
had better representation. Pooling the UniFrac distances to reagents of samples from all
four donors, in all volume levels the pelletted urine samples had higher weighted UniFrac
distances to reagents than whole urine samples. For pelleted urine samples, the weighted
UniFrac distances to reagents tended to stabilize after urine samples have a volume
higher than 20 ml, while for whole urine samples it seemed to need more than 100ml to
reach a decent weighted UniFrac distance to reagents (Figure 18). These results showed
that urine stored in pellets might have a better representation of the urinary microbiota of
the donor. Samples pelleted from a urine sample with a volume higher than 20 ml seemed
to have better representation.

Figure 16. PCOA plot showing weighted UniFrac distances of urine samples stored
in pellets (Group A) with various volume and reagent controls. The volume of each
sample is marked in the figure. For better representation only one sample of each
volume from one donor.
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Figure 17. PCOA plot showing weighted UniFrac distances of pelleted urine samples
(Group A, blue) and whole urine samples (Group B, green) and reagents. The
volume of each sample is marked in the figure. For better representation, only one
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Figure 18. UniFrac distances of samples from all four donors, both in pellets and
whole urine (Group A & B), to reagents.
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We then proceeded to explore if storage time could affect sequencing results. Both urine
pellets (Group C) and whole urine (Group D) were stored in -80℃ for one month, six
months, 1 and two years before they were processed and sent for sequencing. Group C
samples demonstrated a relatively consistent UniFrac distances to reagent through
various time points, while Group D samples showed a more obvious decrease over time
(Figure 18 and Figure 19). When compared to samples that only stored in one month,
Group D samples over time showed a more remarkable increase in weighted UniFrac
distances while Group C sample maintained stable (Figure 19). These results showed that
stored sample over time would decrease in quality, but samples kept in pellets would
mitigate these effects.

Figure 19. PCOA plot showing weighted UniFrac distances of pelleted urine samples
(Group C, blue) and whole urine samples (Group D, red) and reagents. The storage
time of each sample is marked in the plot. For better representation, only one
sample of each volume from one donor is shown here.
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Urine Sample Volume
Figure 20. UniFrac distances of samples from all four donors, both in pellets and
whole urine (Group C & D), to reagents. The black dots showed UniFrac distances of
samples over time to samples stored in one month.

3.3.2 Microbiota pattern of urinary stone patients
3.3.2.1

Characterization of the urinary microbiota of healthy
subjects and stone patients.

A total of 116 urine samples were collected. The demographic information of all donors
is presented in Table 7. We characterised the microbial composition of urine samples
from 41 from healthy individuals (22 female and 19 male) and 61 from stone patients (31
female and 30 male), after excluding samples with bacterial growth exceeding 105
CFU/mL and samples with low sequencing reads. Four hundred and fourteen bacterial
operational taxonomic units (OTUs) in total were identified in the sequencing result. On
average, one sample contained 5338 reads.
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The urinary microbiota patterns of women had higher alpha diversity compared to men,
although there was no statistical significance (Figure 21). An exploratory compositional
biplot of the samples from healthy male and female donors showed that 21.4% and
11.8%, respectively, of the variation could be explained by the first and second
components, and was likely due to the relative abundance of Lactobacillus,
Corynebacterium and Staphylococcus species. The urinary microbiota of the two genders
demonstrated distinct patterns: urine samples from a male donor were most commonly
predominated by a single genus, usually Corynebacterium, Staphylococcus and
Streptococcus, and occasionally by Lactobacillus, Enterobacteriaceae species
(presumably Escherichia coli), Anaerococcus, Gardnerella and Prevotella. Urine
samples from a female donor, on the other hands, consisted of a more heterogeneous
microbial community, usually predominated by Lactobacillus species (Figure 22). When
comparing the urinary microbiota of healthy male and female, it was noted that female
urinary microbiota contained higher proportions of Lactobacillus species, while male
urinary microbiota contained higher proportions of Corynebacterium or Staphylococcus
species (Figure 23-28). qPCR quantification of 16S rRNA gene operon copy numbers
showed that a voided urine sample from a female donor has slightly higher copy number
of rRNA operons than her male counterpart, both healthy subjects and stone patients, but
without statistical significance (Figure 29)
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Table 7. Demographic information of the urinary microbiota study participants (3).
Urinary stone patients
Female (n, %)

Healthy volunteers

31

50.8

22

53.7

20-29

3

4.9

2

4.9

30-39

6

9.8

8

19.5

40-49

16

26.2

8

19.5

50-59

20

32.8

13

31.7

60-69

13

21.3

5

14.6

70-79

3

4.9

5

9.7

Median

51

-

SWL

17

27.9

-

-

URS

37

60.7

-

-

PCNL

7

11.2

-

-

Age (n, %)

Operation (n, %)

102

Figure 21. Relative abundance taxa bar blot of urine samples from healthy
individuals and stone patients. Taxa (groups of 16s rRNA gene sequences) are
represented at the genus level. The dendrogram represents the hierarchical averagelinkage clustering of the microbiota profiles based on the computed weighted UniFrac
distances.
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Figure 22. Distribution of alpha diversity within groups as measured by Shannon
index. The left two boxes represent the calculated Shannon index for urine
microbiota samples from healthy male and female donors while the right two boxes
were samples from male and female patients of urinary stones.
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Figure 23. Compositional biplot of urinary microbiota of healthy male donors (blue)
and healthy female donors (red)
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Figure 24. Box plot of the difference in bacterial abundance between healthy male
and female. Taxa with high effect sizes are shown. The bacterial abundances were
presented in relative abundance as computed by ALDEx2.
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When comparing the urinary microbiota between the healthy individuals and the stone
patients, a trend of separation could be observed in both male and female groups on
biplot, but there was no clear separation (Figure 25 and 27). Male stone patients had
slightly higher relative abundances in Escherichia and Fingoldia species comparing to
healthy donors, while female stone patients had slightly higher relative abundances in
Prevotella, Streptococcus, Finegoldia and Peptoniphilus species, although none of these
differences reached statistical significance (Figure 26 and 28). The analysis based on
weighted UniFrac did not observe a clear clustering of healthy or stone samples at the
genus level (Figure 31). Similarly, no differences in alpha and beta diversity were
observed among the level of stone size, location and composition (data not shown). In
summary, no taxa were found significantly different between stone patient and healthy
individual in both genders in this study.

3.3.2.2

Longitudinal stability of urinary microbiota

The aim was to investigate how the urinary microbiota changed throughout time. Two
samples were collected from each person with approximately three months between
collections (refers to the demographic table). Of all included participants, 70 had their
follow-up sample collected (18/19 healthy male, 19/22 healthy female, 17/30 male stone,
16/31 female stone).
The UniFrac phylogenetic distance metric was calculated to measure the distance of the
samples from one donor of two time points to samples from one donor to another donor.
The UniFrac score ranges from 0 to 1. A lower UniFrac score means higher similarity of
the microbiota between the compared samples to samples with higher UniFrac scores. If
the UniFrac score was 0, it means the microbiota profiles of the two samples were exactly
the same. If the UniFrac score was 1, it suggests two completely microbiota profiles with
no overlapping species. Figure 30 demonstrated the UniFrac distances of samples from
one donor and samples from different donors. Across all conditions (male
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Figure 25. Compositional biplot of urinary microbiota of healthy male donors (blue)
and male stone patients (red)
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Figure 26. Box plot of the difference in bacterial abundance between healthy male
individuals and male urine stone patients. Taxa with high effect sizes are shown.
The bacterial abundances were presented in relative abundance as computed by
ALDEx2.
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Figure 27. Compositional biplot of urinary microbiota of healthy male donors (blue)
and male stone patients (red)
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Figure 28. Box plot of the difference in bacterial abundance between healthy female
individuals and female urine stone patients. Taxa with high effect sizes are shown.
The bacterial abundances were presented in relative abundance as computed by
ALDEx2.
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Figure 29. qPCR estimation of bacterial load in urine pellet samples. The result was
reported as the estimated number of operon copies of 16S rRNA present per urine
pellet.
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Figure 30. Weighted UniFrac distance between samples from one donor (black dots)
and between samples of different donors (white squares). For clearer presentation,
each white square represents the mean weighted UniFrac distance of the first
sample from one donor to the samples of all other donors.
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or female, stone or healthy), samples from one donor collected from two time points had
significantly lower UniFrac scores than samples from different donors, which suggested
the variation of the urinary microbiota of one individual is always smaller than the
difference of urinary microbiota profiles of two individuals. These results suggested that
the urinary microbiota of one individual stays relatively stable throughout time.

3.3.2.3

Mutual support culture-based methods and 16S rRNA
sequencing in microbial detection

Among all 116 urine samples collected, 14 had higher than 105 CFU/mL, and the
participants were excluded. Of the remaining 102 samples, 76 had positive cultures.
Among them, 43 samples were negative for traditional culture but had positive EQUC
culture results. Almost all cultured species had corresponding OTUs in the sequencing
results, and usually, they were the most predominant or second predominant genus in the
sample. Also, there were two cases of interest: in one sample, a colony was retrieved, and
Sanger sequencing confirmed it to be Weeksella virosa. Interestingly, the 16S rDNA
sequencing result of this sample the reads of the OTU attributed to Weeksella only
accounted for only 1.32% of the total reads, while Weeksella virosa is the only microbial
species that was retrieved by culture-based methods. On the other hand, in another
sample, 32.32% of reads were unusually attributed to Ureaplasma species, while routine
culture methods failed to grow any Ureaplasma. However, when Ureaplasma-specific
media and atmosphere (refer to methods section) were utilized, it was possible to culture
Ureaplasma ureealyticum. These results showed that the combination of culture-based
techniques and sequencing-based techniques could yield the highest sensitivity and
accuracy in microbial detection in clinical samples.

3.4 Discussion
In this study, we first sought to optimise the methodology for urine sample storage to
obtain the highest fidelity in 16S rRNA gene sequencing; then we explored the urinary
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microbiota profiles of healthy individuals with culture-based and sequencing-based
techniques. The urinary microbiota of an individual maintained its profile features
throughout the multiple sampling points, making it distinct from the urinary microbiota
from other individuals.
The value of proper sample collection and handling methods can never be underemphasised in microbiota studies. Each sample type has its unique features that must be
taken into account for sample acquisition and processing. Common sample type for
human microbiota studies such as stool, saliva and vaginal fluids have well-established
handling methods (Abrahamson et al., 2015; Goodrich et al., 2014; Kumar et al., 2014;
Ott et al., 2004). However, no consensus has yet been reached on the optimal protocol for
urine sample collection and storage. Unlike stool or saliva, urine samples have their own
features relating to how they perform when processed for microbiota analysis: (a) Low
microbial biomass in urine sample means it tends to be affected by reagent and
environmental contamination (see chapter two) and (b) The liquid form of a urine sample
makes it more susceptible to the freeze-thaw process, as explained below.
Since the microbial biomass in a urine sample from a healthy subject is low, a relatively
large amount of urine is required to have a decent representation of the urinary
microbiota. In this study, as the volume of the urine sample increased, a higher UniFrac
distance score was achieved to reagent controls, suggesting a better representation of the
original urinary microbiota. The UniFrac score was also noted to reach its “plateau
phase” after volume reaches 20 mL, suggesting that this volume may be the minimal
appropriate for urinary microbiota sampling. Several previously published studies
investigating urinary microbiota would use a low urine volume such as 1 ml, 2 ml or 10
ml (Lewis et al., 2013; Nelson et al., 2010; Pearce et al., 2014). Their sequencing quality
may, therefore, be compromised.
Since the DNA extraction of urine samples includes a step of centrifuging the urine
sample and discarding the supernatant, all DNA released into that urine would be lost.
The freeze-thaw process may lead to microbial cellular rupture, releasing their DNA into
the urine and loss following centrifugation. Common cryoprotectants in traditional
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microbiology experiments such as glycerol do not have a DNA-free form that is
compatible with microbiota investigation. Therefore, when the whole urine is frozen in 70℃ without any cryoprotectants, its quality will have a remarkable drop. Keeping urine
in pellets avoids discarding the supernatant, thus transferring all microbial components
into the DNA extraction experiment.
To my knowledge, this is the first report of the optimal storage form of urine samples. As
the technical progress of high-throughput sequencing, many study groups and
commercial companies are planning on sequencing-based studies of urine samples.
Therefore, developing a standard protocol for sample handling and storage is crucial. The
data generated here may provide some reference.
The present study observed different urinary microbiota features between male and
females but did not identify a “stone-related” microbiota, as no clear distinction from
healthy individual and stone patients of the same gender could be found. One possibility
is that there’s no such “stone-related” microbiota, especially in patients with no acute
infective episodes. Another possibility is the inclusion criteria did not specify frequently
recurrent stone patients, or patients with a specific stone composition, which may be
more likely to have a specific urinary microbiota (Maalouf et al., 2012). Alternatively,
the impedance of urine through one ureter may not be detected by used here, or if only
small numbers of bacteria are released this may also be below the levels of detection.
Barr-Beare et al. explored the stone microbiota with both sequencing-based methods and
EQUC and found several known uropathogens including E.coli, Pseudomonas,
Gardnerella et al. in the stone (Barr-Beare et al., 2015), which suggests microbes do
inhabit non-infectious, calcium-based stones. However, other studies also report that
urine samples have lower sensitivity to detect stone-harboured microbes compared to
stone samples, which may explain the inability to identify a stone-specific microbiota in
the urine samples tested here.
The urinary microbiota was found to have its longitudinal stability throughout three
months. Urine samples from one individual in different time points were always more
similar than samples from different individuals. This phenomenon persisted in both
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genders, and in both healthy, and stone donors. It is also worth noting that the urinary
microbiota maintained its stability in stone patients, even after their stone had been
surgically removed. This could also suggest that calculi per se are not major factors of
urinary microbiota profiles, or the time gap of three months was too long to identify the
perioperative disruption of the urinary microbiota. This will be further investigated this in
the next chapter.
To my knowledge, this is the first study reporting the longitudinal changes of the urinary
microbiota. The understanding of the relative resilience of urinary microbiota is crucial
when further studying the effect of antibiotics, surgical intervention and stone
fragmentation to the urinary microbiota, as explored in the next chapter.
In the last series of studies in the present chapter, culture-based methods were compared
to sequencing-based techniques. In most cases, the results overlapped, in the sense that
the culture-retrieved species were invariably identified among the five most predominant
OTUs obtained by sequencing. However, exceptions did exist as the case of Weeksella
species which only consisted of 1.32% of the total reads. This demonstrated the
sensitivity differences of culture-based methods and sequencing-based techniques. The
former, although unable to culture all species, was sensitive enough to recover even one
single microbial cell, at least in theory. While sequencing-based methods tended to lose
their detection accuracy for microbes at very low abundance since the reagent noise was
at 103 copy/ml. Therefore, if the microbe of interest can be cultivated, the culture-based
methods have higher sensitivity than sequencing-based techniques in microbial detection.
On the other hand, there’s no single culture method that could cover all spectrum of
known microbes, making it time-consuming work. Therefore, sequencing techniques can
act as a “guide” for specific culture methods to be employed to recover microbes of
interest.
In conclusion, urine samples for microbiota studies should be stored in centrifuged pellet
form. The urinary microbiota has gender-specific features, and have relative resilience in
its microbial structure over time. No specific microbiota profiles were identified in this
study.
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Chapter 4

4

Perioperative urinary microbiota and its association with
infectious complications following extracorporeal shock
wave lithotripsy of metabolic stones.

4.1 Introduction
Urolithiasis, also known as urinary stones, is among the most common urological
conditions (Scales et al., 2012). In the United States, urinary stones take up about two
million outpatient visits annually. The incidence seems to be on the rise, in the United
States, from 3.8% in 1976-1980 to 8.4% in 2007-2010 (Scales et al., 2012; Stamatelou et
al., 2003). The condition has a detrimental effect on the kidney, with obstruction
compromising renal functions, which can lead to renal failures. Studies have shown that
28% of staghorn calculi (a large stone that takes up more than one calyx) patients will
develop renal function deterioration in eight years (Teichman et al., 1995). Urinary
stones can also induce infections due to urinary stasis. This can develop into lethal
urosepsis (O’Keeffe et al., 1993).
Bacterial infections have themselves been associated with certain types of urinary stones.
These are usually called “infections stones or struvite stones”. These are thought to be
caused by urease-producing bacteria (Naber et al., 2011), although this has recently been
challenged because these microorganisms are not always recovered from the stone
(Yoshida et al., 1984).
The chemical composition of infectious stones can comprise mono-ammonium urate,
struvite (magnesium ammonium phosphate) and carbonate apatite. Common ureaseproducing bacteria causing infection stones include E.coli, Proteus species, Klebsiella
species, Staphylococcus species, and Pseudomonas species, etc. (Bichler et al., 2002).
Other stone types, for example, those composed of calcium oxalate are thus considered
“non-infective stones”. They are believed to form without microbial involvement.
However, despite meticulous preoperative screening and prophylaxis, infective
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complications still occur frequently, following lithotripsy surgery (Borghi et al., 2012;
Golechha et al., 2001).
Common surgical options for urinary stone management include extracorporeal shock
wave lithotripsy (ESWL), percutaneous nephrolithotomy (PCNL) and endoscopic
procedures.
Firstly introduced in the early 1980s (Chaussy et al., 1984), ESWL has revolutionised the
treatment of urinary stones. Its ease of use, non-invasive nature and high efficiency have
rapidly won global acceptance. Despite these advantages, complications can occur in
three categories: stone fragment-associated complications, infection-associated
complications and tissue damage (Table 8). Infectious complications include bacteriuria,
UTI and sepsis. For the more serious complications such as sepsis, bacteria in urine enter
the bloodstream facilitated by renal trauma and vascular disruption induced by the
ESWL. This is especially the case for infectious stones, where bacteriuria can be detected
through postoperative urine culture (Michaels et al., 1988). However, even in noninfection stone patients, postoperative bacteriuria still happens in 5.8% of cases (Mira
Moreno et al., 2014). In 1997, Pearle et al. performed a meta-analysis performed on eight
randomised controlled trials (RCTs) investigating the effect of antibiotic prophylaxis on
ESWL patients, concluded that antibiotic prophylaxis is beneficial and reduces the postESWL complication rate (Pearle & Roehrborn, 1997). This led to the American
Urological Association (AUA) recommending antibiotic prophylaxis for ESWL until
2012 when new evidence questioned the efficacy (Honey et al., 2013; Lu et al., 2012;
Wiesenthal et al., 2011). Today, both the AUA and European Association of Urology
(EAU) guidelines do not recommend antibiotic prophylaxis, unless the patient has an
increased risk of infection.

123

Table 8. Common complications following ESWL and PCNL (Skolarikos et al.,
2006)
Complications after ESWL for urinary stones
Related to stone fragments
•
•
•
•

Incomplete fragmentation
Residual stone fragments
Steinstrasse
Obstruction

Infections
•
•
•

Asymptomatic bacteriuria
Urinary tract infection
Sepsis

Tissue effects
•
•
•
•
•

Renal (hematoma, hemorrhage)
Cardiovascular effects
Gastrointestinal effects
Genital system
Foetus

Complications after PCNL for urinary stones
Acute
• Damage to vascular endothelium
• Damage to nephron, renal tubules and interstitium
• Loss of corticomedullary demarcation
• Increased extraction in urine of metabolites indicating renal damage
• Haematuria
• Hematoma
• Decrease in GFR
• Decrease in effective RPF
Chronic
• New onset of hypertension
• Perirenal fibrosis
• Loss of renal function
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Compared to ESWL, PCNL is a surgical procedure required to remove larger stones or
those refractory to non-invasive procedures. Infective complications of PCNL are more
common, in that one-third of cases have an infection-related episode (Cadeddu et al.,
1998). Despite the fact that only struvite stones are currently considered as having a
bacterial nidus, bacteria have been detected in other common stone types, such as
calcium oxalate and calcium phosphate stones (Bratell et al., 1990; Dewan et al., 1997;
Gault et al., 1995; Hugosson et al., 1990; Larsen et al., 1986; Lewi et al., 1984;
McCartney et al., 1985). During lithotripsy, stone fragmentation may potentially release
bacteria into the bloodstream, increasing the risk of urosepsis. Therefore, evaluating the
risk of postoperative UTI especially urosepsis is of importance. In routine practice, a
urine culture is usually performed one week prior to surgery to exclude active infection,
and antibiotic prophylaxis (commonly fluoroquinolones) is applied if positive. Patients
do not typically undergo their surgery until the urine culture is clear of any evidence of
infection, as the EAU guidelines recommend (Türk et al., 2017). Despite these efforts,
life-threatening systemic infections can occur after lithotripsy surgery. This raises the
question whether there are bacteria present in non-infectious stones that contribute to
postoperative bacteriuria and other infective complications.
In this study, we hypothesise that bacteria exist within non-infectious stones, such as
those composed of calcium oxalate and phosphate are released into urine during
lithotripsy surgeries. We sought out to determine whether their 16S rRNA gene
sequencing and enhanced culture from urine and stone samples would be able to detect
these organisms.

4.2 Materials and methods
4.2.1 Clinical samples and study design
The protocol of this study was approved by the human research ethics board, Western
University, Canada and West China Hospital, Sichuan University, China. Participants in
this study were patients admitted to St. Joseph Hospital or West China Hospital.
Inclusion criteria were that the participants: at least 18 years of age, non-pregnant, no
other infectious diseases, not receiving antibiotic or chemotherapy. The diagnosis of
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urinary stone was confirmed with the radiological investigation, and the patient then
received either ESWL or PCNL. Patient information including gender, age,
comorbidities, size of the stone along with number, location and composition of the
stones were recorded. After inclusion, participants in the ESWL group were asked to
provide three urine samples: one in the operating room before ESWL, plus one collected
as the first voided urine after ESWL, and one at the follow-up outpatient clinic.
Participants of the PCNL group provided preoperative voided urine 1-3 days before the
surgery, and a postoperative urine collected via Foley catheter within 24 hours of surgery.
A renal pelvic urine sample and a stone sample were also collected during the PCNL
surgery. Complications were noted from medical records. All patient information was
maintained by a research coordinator, and were blind to other members of the research
group until all sample processing, and DNA sequencing work was completed. Patients
were de-identified after retrieval of their demographic information for statistical analysis.

4.2.2 Sample collection
4.2.2.1

Voided urine

All participants were instructed to wash their hands thoroughly with soap and water, then
to clean and wash their external genitalia with an antiseptic towelette. Urine samples
were taken with a clean-catch, midstream voided fashion: the first 10 mL was discarded,
the majority of the voided volume collected in a sterile container, and the final voided
volume dispensed into the toilet. Once collected, all urine samples were processed within
one hour. Microbiological cultures were performed subsequently, and the remaining of
urine samples were spun down to pellets and stored at -80 ℃.

4.2.2.2

Renal pelvic urine samples

During PCNL surgeries, after the ureteral catheter were inserted the patient and set in
prone position. At this point, after sterile preparation, the percutaneous access was
established with a 14-gauge Kellet needle. When the needle tip reached the renal
collection system, urine was emitted from the rear end of the needle, and collected as the
renal pelvic urine sample.
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4.2.2.3

Stone samples

Urinary stone fragments were collected during PCNL, and transferred by the surgeon or
nurse to a sterile container using aseptic techniques. Stone samples were then transferred
to the lab, where the procedures for cultural analysis was performed within 4 hours. In
brief, the surface of the stone was washed five times with sequential falcon tubes
containing 75% ethanol in the first one and DNA-free water in the remaining four tubes.
The stone fragments were then transferred to a sterile mortar, crushed, then aliquoted for
traditional or EQUC culture analysis and 16S rRNA gene sequencing.

4.2.3 Microbiological culture
All collected samples were quantitatively cultured on self-made Colombia Blood Agar
with 5% sheep blood, LB agar and MacConkey agar. Urine samples with a CFU > 105
per mL were considered to represent an active UTI and excluded, as per standard
protocol (Pickard et al., 2016). All cultivated strains were isolated and stored. EQUC was
also applied following protocols developed by Hilt et al. (Hilt et al., 2014). In brief, urine
samples were cultured with higher volume input (100 ul and up to 1 ml), enriched culture
media (CBA, CAN agars and thioglycolate medium), both aerobic and anaerobic culture
atmosphere and extended culture time (up to 5 days). Morphologically unique colonytypes were re-isolated for taxonomic identification. The details of microbiological culture
media used in this study are in the appendix.

4.2.4 DNA extraction
The samples were thawed on ice and DNA-extracted with MOBIO Powersoil® kit. The
DNA extraction protocol was similar to ones used in Chapter three. In brief, lysis buffer
and beads were added to urine or urine pellets. Lysis of cells was achieved with
mechanical and chemical methods. The suspension was then transferred to a new tube,
and the subsequent procedure was following manufacturer’s instructions.

4.2.5 16S rRNA gene library generation and sequencing
Extracted DNA from the clinical samples were PCR-amplified with barcoded primers as
described by Gloor et al. (2010) shown in Appendix A. The PCR was performed in a 42-
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μl reaction system, with details listed in Appendix B. Following PCR, the amplicons
were quantified with the Qubit 2.0 fluorometer (Invitrogen, CA, USA). Equimolar
amounts of each amplicon were aliquoted into a single tube purified with the QIAquick
purification kit (Qiagen, Mississauga, ON, Canada). Each product was then pooled and
sequenced on the Illumina Mi-Seq platform in a paired-end run using a 600 cycle kit with
a paired-end 220-bp run at the London Regional Genomics Center (Robarts Research
Institute, London, ON, Canada), following standard operating procedures.

4.2.6 Sequence processing and taxonomic assignment
Description of the processing algorithm has been previously published (Gloor et al.,
2010). The SOP and related software are accessible at
http://github.com/ggloor/miseq_bin. The sequences were processed following algorithm
as stated in Appendix C. Paired-end reads were overlapped with Pandaseq V2.5 (Masella
et al., 2012), allowing no ambiguous positions in the overlapped reads. Reads were then
demultiplexed and tagged with the name corresponding to the sample identifier and
barcode. After demultiplexing, reads from all samples were merged into one single file
and were clustered into individual sequence units (ISUs), which were then further
grouped into operational taxonomic units (OTUs) with open reference OTU picking
method, using Uclust algorithm of USEARCH version 7, which has a de novo chimera
filtering step built into it (Edgar et al., 2010; Edgar et al., 2015). The identity threshold
was 97%. Singleton OTUs and ones with abundance < 1% were discarded. Taxonomical
assignment was performed with mothur 1.3.4 to annotate the OTU sequences against the
Silva database (v119).

4.2.7 Bioinformatic analysis
Compositional data transforming was done using centred log ratios (clr) by custom R
codes, linear sample independence, and normalization of read counts. K-means clustering
of the data was performed using Euclidean distances on CLR-transformed data with a
uniform prior of 0.5 added to each value before transformation. The ALDEx R package
version 2 was used to compare the relative abundances of genera (fernandes et al., 2014).
Values reported in the manuscript represent the expected values of 128 Dirichlet Monte-
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Carlo instances of clr-transformed data. A value of zero indicated that organism
abundance was equal to the geometric mean abundance. Thus, organisms more abundant
than the mean would have positive values, and those less abundant than the mean would
have negative values. Base 2 was used for the logarithm so that differences between
values would represent fold changes. Significance was based on the Benjamini-Hochberg
corrected P value of the Wilcoxon rank test (significance threshold P < 0.1) (Gloor et al.,
2017).

4.2.8 qPCR estimation of 16S rRNA gene copy numbers.
The bacterial load in the urine samples were estimated by qPCR quantification of the
DNA extracts. The reaction system includes 10ul of PCR master mix, 5 ul of 800Nm
primer stock (V6 hypervariable region of 16S rRNA gene: V6-LT 5’ CCATCTCATCCCTGCGTGTCTCCGACTCAGNNNNNCWACGCGARGAACCTTA
CC3’
and V6-RT: 5’CCTCTCTATGGGCAGTCGGTGATACRACACGAGCTGACGAC 3’)
Apprill et al., 2015), 5ul of sample DNA template. A standard curve was constructed
using the values returned using the above methodology with known copy numbers of
E.coli DH5a gDNA.

4.3 Results
4.3.1 Characterization of urinary microbiota of urinary stone patients
receiving ESWL
A total of 57 urine samples from 21 urinary stone patients receiving ESWL were
collected. The median age of participants was 53. After exclusion of urine samples that
had positive preoperative routine urine culture results, sequencing results of 51 urine
samples from 12 male and five female stone patients went through downstream
bioinformatic analysis. A total of 414 OTUs were identified from the returned sequences.
On average, each sample contained 1938 DNA sequencing reads.
The composition of the urinary microbiota appeared to be similar to those detailed in
other chapters. The female urinary microbiota had a comparatively higher alpha diversity
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than males and was commonly predominated by Lactobacillus species. The male urinary
microbiotas were usually predominated by a single genus, commonly Corynebacterium,
Staphylococcus or Streptococcus (Figure 31). qPCR quantification of 16S RNA operon
copy numbers showed that voided urine samples from female donors had a slightly
higher copy number of rRNA operons than males, irrespective of healthy or stone status,
but this was not statistically significant (Figure 32).
The sequencing results had considerable overlap with the EQUC results of the urine
samples. A total of 24 isolated strains from nine genera were cultured, with the majority
of which also confirmed in 16S rRNA gene sequencing (Figure 33). The overlap of
sequencing and culture results further confirmed the evidence of viable bacteria
inhabiting in the urinary tract of urinary stone patients.

4.3.2 Immediate postoperative urine showed signs of bacteria
released into urine
The urinary microbiota profile immediately before and then after ESWL was undertaken
with urine samples from 17 urinary stone patients receiving ESWL. The Shannon index
was calculated as alpha diversity (species richness and evenness of a given sample) and
weighted UniFrac phylogenetic distance metric as beta diversity (the difference of
species composition between two samples) of immediate preoperative and immediate
postoperative samples. The alpha diversity of immediate post-operative urine samples
demonstrated remarkable change comparing to preoperative samples. The follow-up
samples, on the other hand, had their Shannon diversity index score more similar to
preoperative samples, making the difference of Shannon diversity index score between
follow-up samples and preoperative samples significantly lower than the difference
between immediate post-operative samples and preoperative samples (Figure 34).The
beta diversity of urine samples before and after ESWL demonstrated similar fluctuations.
The weighted Unifrac distances of samples from one donor at various time points were
measured. The weighted UniFrac distances between immediate postoperative samples
and preoperative samples were significantly higher than distances between follow-up
samples and preoperative samples (Figure 35).
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Of the immediate postoperative samples, there were OTUs that were not present in
preoperative samples and reagent controls, or only constituted a small proportion in the
preoperative samples. In the 16s rRNA gene sequencing results, 12 of 17 immediate
postoperative samples had increased relative abundance of certain taxa, and in 7 of these
12, the microbial taxa with relative abundance change were retrieved using culture-based
methods (routine urine culture and EQUC) (Table 9). This group of immediate
postoperative urine samples that have “microbial fluctuation”, also had higher weighted
UniFrac distances to preoperative urine samples compared to the rest of the immediate
postoperative urine samples (Figure 36). However, no significant difference in qPCRestimated 16s rDNA operon copy number was observed. (Figure 37). In summary, these
results suggest the release of microbes into urine during ESWL.
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Figure 31. Relative abundance taxa bar plot of urine samples from urinary stone
patients receiving extracorporeal shock wave lithotripsy (ESWL). Taxa (groups of
16s rRNA gene sequences) are represented at the genus level. The dendrogram
represents the hierarchical average-linkage clustering of the microbiota profiles
based on the computed weighted UniFrac distances.
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Figure 32. qPCR estimation of bacterial load in urine pellet samples. The result was
reported as the estimated number of operon copies of 16S rRNA present per urine
pellet. Bars in plot indicate median and interquartile range
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Figure 33. Heatmap comparing taxa detected by 16S rRNA gene sequencing and
culture-based techniques. Each square was colour-coded based on the detection
status of a given taxa. Green means detected by sequencing only, red means detected
by both methods, blue means detected by culture only and grey means not detected
by either method.
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Figure 34. Shannon’s diversity of urine samples from stone patient receiving ESWL.
(a) Change in Shannon’s diversity of urinary microbiota before and after ESWL.
Samples from one donor were connected by lines. (b) Dot plot shows differences of
alpha diversity from immediate post-operative samples and follow-up samples to
pre-operative samples.
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Figure 35. Dot plot showing weighted UniFrac distances index between preoperative
samples to immediate postoperative samples and follow-up samples. Each dot stands
for the weighted UniFrac distances index from the current condition (immediate
post-operative or follow-up) to the preoperative urine sample from the same donor.
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Table 9. Changes in relative abundance of taxa in immediate postoperative urine
samples.
Donor

Urotype

Postoperative sequencing

Culture results

fluctuation
1

Staphylococcus

2

Streptococcus

3

Gardnerella

Enterobacteriaceae spp.

Staphylococcus
Streptococcus

Enterobacteriaceae spp.，

Enterobacteriaceae spp.

Lactobacillus
4

Corynebacterium

Corynebacterium

5

Streptococcus

Pseudomonas

Streptococcus, Pseudomonas

6

Corynebacterium

Staphylococcus

Corynebacterium, Staphylococcus

7

Corynebacterium

Enterobacteriaceae spp.

8

Gardnerella

Staphylococcus

Gardnerella, Staphylococcus

9

Gardnerella

Actinobaculum

Gardnerella, Actinomyces

10

Streptococcus

Staphylococcus

Streptococcus, Enterobacteriaceae

11

Corynebacterium

12

Lactobacillus

Enterobacteriaceae spp.

Enterobacteriaceae spp.， Lactobacillus

13

Lactobacillus

14

Lactobacillus

Porphyromonas

Pseudomonas, Weeksella

15

Lactobacillus

Staphylococcus, Actinobaculum

Staphylococcus, Lactobacillus

16

Corynebacterium

17

Lactobacillus

Lactobacillus

Enterobacteriaceae spp.
Staphylococcus

Enterobacteriaceae spp.,Gardnerella

* In this table, “Urotype” shows the most predominant taxa in the 16s rRNA gene sequencing result,
and “Postoperative sequencing fluctuation” shows taxa that have the highest degree of change in
their relative abundance in the in the 16s rRNA gene sequencing result. “Culture results” showed
strains isolated from routine urine culture and EQUC.
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Figure 36. Comparison of weighted UniFrac distances of urine samples between
groups that have “microbial fluctuation” in immediate postoperative samples. That
is, taxa that have a remarkable increase in relative abundance and also confirmed in
culture-based methods, and other samples. Each dot in the plot represents the
weighted UniFrac distance of this sample to the preoperative sample of the same
donor.
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Figure 37. qPCR estimation of bacterial load in immediate postoperative urine
samples. The “microbial fluctuation” groups stand for urine samples that have taxa
with a remarkable increase in relative abundance and confirmed by culture-based
methods. The result was reported as the estimated number of operon copies of 16S
rRNA present per urine pellet.
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4.3.3 Correlation of stone and urine microbiota profile further
confirmed bacteria in stone
To further confirm that the post-ESWL detected bacteria cames from the stones, pelvic
urine samples and stone samples were collected together with preoperative and
postoperative voided urine sample from six patients receiving percutaneous
nephrolithotomy (PCNL). Of these, the stone samples of two patients of six patients had
positive 16S rRNA gene sequencing results (i.e., a microbiota profile distinct from reagent
control profiles).
The first patient was a 46-year-old male whose preoperative urine sample presented a
Corynebacterium-predominated profile, while his stone sample had DNA sequences
attributable to Staphylococcus. The pelvic urine samples and voided postoperative urine
sample also had a high proportion of Staphylococcus in sequencing results which coincided
with the stone sequencing results.
The second patient was a 52-year-old female whose preoperative voided urine sample was
predominated by Gardnerella and Lactobacillus. The stone microbiota consisted mainly
of Actinobaculum and Enterobacteriaceae spp, which are also major components of the
urinary microbiota in the patient’s pelvic urine and a postoperative voided urine sample
(Figure 38).
These results suggest that it is highly likely that the newly-emerged bacteria in the
postoperative urine may come from the stone during lithotripsy.
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Figure 38. Relative abundance taxa bar plot show microbiota profiles from two
PCNL patients kidney stones plus various urine collections.
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4.4 Discussion
In this study, the urinary microbiota was noted to fluctuate following lithotripsy surgery,
suggesting the origin of the bacteria was the stone itself.
Traditionally, urinary bacteria have not been implicated in calcium oxalate or calcium
phosphate stones. However, postoperative infective complications do happen after
lithotripsy surgeries, despite negative preoperative urine culture and antibiotic
prophylaxis. Several studies now have reported that bacteria can be isolated from nonstruvite urinary stone samples, even with routine urine culture methods (Mariappan et al.,
2005; Mufarrij et al., 2012; Songra et al., 2016). These reports suggest the existence of
bacteria in “non-infective” stones. In our study, we observed a “microbial fluctuation”
phenomenon in the immediate postoperative urine samples, that is, an increase in relative
abundance of several microbial taxa that either did were not present before ESWL or
were in low abundance.
When designing the study, attempts were made to eliminate confounding factors that
could have an impact on the urinary microbiota. None of the patients in this study was
receiving antibiotic prophylaxis during ESWL. Since ESWL uses externally applied
focused shock wave to fragment the stone, no invasive instrumentation or procedures
were taken during stone fragmentation in ESWL. This setting excluded most factors that
affect the urinary microbiota. Although, theoretically bacteria could be liberated from
epithelial cells during lithotripsy, the correlation of stone and urine sequencing results
suggested that the “microbial fluctuation” likely resulted from the fragmentation of the
stone.
It was interesting to note the correlation of microbiota profiles between stone samples,
renal pelvic urine samples and immediate postoperative samples. The microbiota
associated with stones and upper tract urine samples had different features than
preoperative voided urine samples: the latter was invariably similar to the genitalia:
Lactobacillus-predominant for female, and Corynebacterium or Staphylococcus for a
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male. The stone samples and “microbial fluctuation” taxa in postoperative urine samples
in our study, on the other hand, had Staphylococcus, Actinobaculum, Pseudomonas and
Enterobacteriaceae spp. (presumtively E.coli) as the major taxa in sequencing results.
Barr-Beare et al. (2015) sequenced stones from five paediatric patients and found
Enterobacteriaceae, Pseudomonas, Gardnerella, Bradyrhizobium, Phyllobacterium and
Brucella 16S rRNA gene homologies. Of note, many of these stone-associated microbes
are known uropathogens (Kass et al., 2002; Salem et al., 2015; Tavassoli et al., 2012;
Woolfrey et al., 1986), which again links UTI and urinary stone formation. Urinary stone
patients are more likely to develop UTIs (Holmgren et al., 1989; Hugosson et al., 1989),
and stone culture studies also showed 19-32% of calcium oxalate stones are bacteria
positive (Tavichakorntrakool et al., 2012; Wang et al., 2014). Barr-Beare et al.
(2015)also showed that bacteria and urinary stones have mutual facilitating effects on
their pathogenesis progress in the formation of calcium oxalate crystals. The role of
bacteria in the formation of calcium oxalate and other non-infective stones warrants
further study.
Post-ESWL bacteriuria and bacteremia are not uncommon for patients with infection
stones (Michaels et al., 1988; Müller-Mattheis et al., 1991). However, the incidence of
postoperative bacteriuria for non-infection stone patients is as low as 5.8%, when using
routine urine culture methods (Mira Moreno et al., 2014). In our study, the postoperative
“microbial fluctuation” phenomenon was identified from 70.6% of postoperative urine
samples(12 out of 17), and both 16S rRNA gene sequencing and EQUC could detect this
“microbial fluctuation” phenomenon in 41.2% of all immediate postoperative urine
samples (7 out of 17 samples), suggesting a higher sensitivity than traditional culture
methods. Admittedly, the “microbial fluctuation” phenomenon observed in this study is
much milder than the traditional definition of bacteriuria, as it neither reached the
required CFU threshold on routine urine culture nor caused any symptoms.
In summary, some patients with non-infection urinary stones appear to have bacteria
released from their kidney stones when disrupted by ESWL. This has clinical
ramifications if release of these organisms induces infection. The results should not be
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taken as recommending antibiotic prophylaxis for all stone patients, as it is not clear that
these drugs will prevent infection, or that their use is justified if the infection rate is low.
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Chapter 5

5

General Discussion

5.1 Study of the microbiota in the urinary tract
5.1.1 Problems of applying 16S rRNA gene sequencing analysis to
low abundance microbiota
The introduction of culture-independent, sequencing-based microbial analytic methods
has greatly reshaped the understanding of microbes inhabiting a human body that many
of these microbes can’t be retrieved by routine traditional microbial culture methods. The
awareness that not all bacteria present in clinical samples could be cultivated dates back
to “The Great Plate Count Anomaly” phenomenon that microscopically identified
microbial cell numbers might not coincide with the number of colonies in the Petri plates
(Staley & Konopka, 1985). Now with the power of sequencing-based techniques, the
number of bacterial phyla (i.e., the highest level of taxonomical divisions under bacterial
kingdom) has increased from 11 in 1987 to at least 85 at present, with many that have
still to be cultivated (Achtman & Wagner, 2008; Keller & Zengler, 2004; Rappé &
Giovannoni, 2003; Woese, 1987). These findings further promoted the investigation of
the presence of bacteria at sites considered likely to be microbes-rich, including brain,
breast tissue, blood, placenta and subepidermal tissue etc. in human body (Aagaard et al.,
2014; Branton et al., 2013; Emery et al., 2017; Justesen et al., 2010; Nakatsuji et al.,
2013). Most of these studies claim the existence of “tissue-associated microbiota”, and
their potential role in the pathogenesis of diseases. However, a study by Salter et al.
revealed that a remarkable proportion of sequencing reads were attributed to background
noise from environment and reagents (Salter et al., 2014). This study revealed the
awareness of increased risk in analysing samples with low microbial biomass (Weiss et
al., 2014).
In this study, we further demonstrated that besides contamination from environment and
reagent, the host DNA could also compromise the quality of microbiota study in multiple
levels.
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First, we showed that high host DNA abundance would saturate commonly-used DNA
extraction kit columns. These extraction kits rely upon columns that have silicone filters
to bind the DNA from the sample. Two of the most commonly used DNA extraction kits
for gut microbiota studies include the Qiagen QIAamp® and MOBIO Powersoil® (now
Qiagen) products. The QIAamp® column has a binding capability of up to 4-12 ug DNA
per filter, whereas, the Powersoil® has a capacity up to 20 ug per filter (Manufacturer’s
manuals). Given that most gut microbes have a genome size around 4-6 Mb, this binding
capability could retrieve presumably as high as 109 copies of bacterial gDNA, which
when amplified, sequenced and analysed would provide a reliable representation of gut
microbial communities. However, when it comes to tissue samples with low prokaryotic
and high eukaryotic cell components, given that eukaryotic cells have a much higher
genome size (e.g. 3000 Mb homo sapiens genome), a DNA collection filter as used in a
commercial extraction kit, could only hold the DNA contents of around 6.5 x 106 cells in
theory. If we assume that the rate of binding is the same for bacterial to host DNA, it
would mean that only a small amount of bacterial DNA would be captured because the
binding capacity of the column would rapidly be exhausted by the eukaryotic DNA.
Since one gram of solid tumor is estimated to have 108 to 109 cells (Del Monte et al.,
2009; Rasnick et al., 2002), therefore, a common input of 200 ug of this tissue as used in
some of our studies, could contain 2 x 107 to 2 x 108 cells, rapidly saturating the DNA
extraction columns. Given this and the low prokaryotic/eukaryotic cell ratio, the
prokaryotic DNA yield could be very low in these columns and bear the risk of poor
representation of the sample microbial communities that they are obtained from and the
importance of confirmatory analysis by culture.
Secondly, we showed that the presence of disproportionately high host DNA abundance
inhibits PCR amplification when using the bacterial specific 16S rRNA gene primers.
The inhibiting effect of non-target DNA on PCR amplification performance is well
known in molecular biology (Ludwig & Schleifer, 2000). However, compromised
microbial rRNA gene amplification seems to be less recognised. Grice et al. (2008)
reported that a eukaryotic/prokaryotic gDNA ratio of 1 to 100 would not significantly
alter 16S rRNA gene amplification, however, our data shows that as the ratio continues to
increase, amplification efficiency drops remarkably when eukaryotic/prokaryotic gDNA
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ratio above 103 (Figure 6a and 6b in Chapter Two). Samples with a higher ratio would
have a poor microbial community representation after DNA extraction and PCR
amplification (Figure 6c and 6d).
Thirdly, we showed that the unspecific amplification of host DNA could take a
remarkable proportion of the sequencing depth. Host DNA consuming sequencing depth
is a known issue in whole genome sequencing and RNA sequencing (Feehery et al.,
2013). Studies with whole genome shotgun sequencing in the presence of large amounts
of host eukaryotic DNA have shown that the background DNA will consume significant
amounts of sequencing depth, making sequencing inefficient, time-consuming and
inaccurate (Feehery et al., 2013). From these studies, it appears that the sequencing depth
of 16S rRNA gene sequencing the presence of a high predominance of host DNA is also
compromised.
Besides host DNA, samples with low microbial biomass are associated with risks of poor
sequencing results as well. Recently Salter et al. showed that a low level of background
DNA contamination is ubiquitous and almost inevitable for a sequencing-based
microbiota studies (Salter et al. 2014; Weiss et al., 2014). Fecal samples have
tremendously rich microbial content, whose 16S rRNA gene sequencing reads will
indubitably overshadow the background noise. However, samples with low microbial
biomass have their microbial DNA at a comparable level to contaminating DNA and is
thus more vulnerable to sequencing bias and within-sample heterogeneity (Kennedy et
al., 2014). In fact, as microbial gDNA concentration in a sample goes lower, the reads
from background contamination will take increasing proportions of the result, which will
lead to a complete background contamination sequencing result for an extremely low
abundance sample (Salter et al., 2014). It is, therefore, important to identify a lower limit
of the microbial biomass of samples that could yield a decent sequencing result. We thus
recommended sequencing serially diluted mock samples to identify this lower limit, then
estimate the sequencing quality before the sequencing the samples.
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5.1.2 Value of an optimised sample processing algorithm
As the fore-mentioned risk factors exist, processing samples with the high host to low
bacterial gDNA ratios (“high-low” samples) with a protocol similar to ones used in the
gut microbiota studies may greatly compromise analysis quality. Therefore, an adapted
protocol is required. In the second part of Chapter Two, we developed a quality-checking
tool and a refined algorithm which is considerate of these sample types. The aim of the
refined algorithm is to mitigate the negative effect of high host DNA abundance and low
microbial biomass.
The photo-activated DNA binding compound, propidium monoazide (PMA) has
previously been used in microbiota studies when analyzing environmental samples with
very low estimated microbial biomass, including ocean (Galand et al., 2009), cleanroom
environments (Weinmaier et al., 2015), and even international space stations(Checinska
et al., 2015; Venkateswaran et al., 2014) . It has been used to differentiate DNA from
living microbial cells to that from free extracellular DNA or DNA present within dead
cells (Emerson et al., 2017). Living microbial cells have intact cell membrane, which
prevents PMA cellular uptake and subsequent DNA binding. This technique is also being
used in fluorescence staining with flow cytometry, where the proportion of living
microbes in drinking water are approximately 70-80% (Berney et al., 2008; Luna et al.,
2002; Yokomaku, Yamaguchi, & Nasu, 2000), and 50-60% in surface fresh water,
estuarine and coastal marine stations (Freese, et al., 2006; Schumann et al., 2003). The
limitation of this membrane integrity-based technique includes (1). It lacks
differentiability in dying cells because the membrane does not instantly disintegrate. (2).
PMA cant evaluate the viability of microbial forms with strong wall structure such as
spores (Berney et al., 2008; Bosshard et al., 2009; Lisle et al. 1999).
Microbial DNA enrichment kits are commonly used in whole genome sequencing, where
eukaryotic host DNA and microbial DNA are both present. Various mechanisms are
utilised in commercial microbial enrichment kits to deplete eukaryotic DNA. The
NEBNext® Microbiome DNA Enrichment kit from New England Biolab uses a
methylated CpG-specific binding protein to bind methyl-CpG that only present in
eukaryotic cells, while the Molzym's MolYsis kit selectively lyse human cells using
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chaotropic reagents, then degrades all extracellular DNA with DNase (Thoendel et al.,
2016). Sequencing of 16S rRNA gene amplicon specific primers typically won’t amplify
human DNA, however, we have shown in chapter two that in “high-low” samples, host
DNA could inhibit PCR amplification and that unspecific amplification consumes
sequencing reads. Therefore, microbial enrichment kits remain as a useful tool to deplete
host DNA when handling “high-low” samples for 16S rRNA gene sequencing.
Although the techniques mentioned above have been previously reported, here we are
first to report that silicon-based filters in DNA extraction kits should be avoided. By
doing this and substituting for an alternative DNA collection technology, such as the
traditional ethanol precipitation, much higher microbial DNA yield will be realized for
these “high-low” samples.

5.1.3 Verification of a microbiota in renal tissue
In Chapter two, we examined renal tumour and healthy adjacent tissue from the same
individuals for the presence of bacterial microbiota. The conventional medical doctrine is
that the upper urinary tract is considered to be “sterile”. Conditions such as pyelonephritis
are thought to typically occur where urinary obstruction can be present in the urogenital
tract and the result of reflux and opportunistic ascending microorganisms. Obstruction
can be the result of urolithiasis, stricture and the presence of tumours. The former has
been reported in early investigations of the bacterial composition of kidney stones which
appear to show the presence of E. coli (Barr-Beare et al., 2015) and is potential evidence
which suggests that trace amounts of bacteria exist in the upper urinary tract.
Of note, uropathogens such as E.coli were able to invade into kidney urothelial
cells(Chassin et al., 2008; Pichon et al., 2009) and form intracellular bacterial
communities (Eto et al., 2006) , and then move even deeper and form quiescent
intracellular reservoirs (Hunstad & Justice, 2010) . In this way, rather than adhering to
the luminal surface of urothelial cells, bacteria could also move deeper into the
parenchymal tissue, where they were able to avoid antibiotics and host immune response.
Bacteria in these reservoirs maintained minimal metabolic activities and usually could
not be cultivated, but they could restore their activity and cause subsequent recurrence or
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asymptomatic infection (Lewis et al., 2007). Through the development of DNA
extraction methods, our study supports the existence of bacteria in renal parenchyma
tissue.

5.2 Urinary microbiota profiles of healthy individuals and
urinary stone patients
5.2.1 Urine sample storage form and sequencing quality
Sample processing and storage methods are arguably the most critical steps in microbiota
studies since it has a high risk of influencing microbial profiles. It has been reported in
gut microbiota studies that sample storage methods can significantly affect faecal
microbiota profiles (Choo et al., 2015; Gorzelak et al., 2015; Nsubuga et al., 2004).
Optimal preparation, handling and storage protocols for stool samples have also been
proposed as a standard methodology (Gorzelak et al., 2015). Unfortunately, for urine
samples, there have no optimised storage methods yet reported. In the first part of
Chapter Three, we performed experiments to investigate how sample volume and storage
form could affect the microbiota sequencing analysis results. Urine samples with greater
than 20 ml in volume, which were stored in centrifuged pellets gave the same consistent
results. Any smaller volumes collected tended to reflect the background contaminating
sequences to some degree.
With the exception of stool samples, studies focusing on the optimal preparation,
handling and storage methods for next generation sequencing-based microbiological
studies are rather limited. Part of the reason for that is that simple act of culturing urine
can be performed almost immediately after the samples collection, so there’s no need for
extended sample storage solutions. However, for sequencing-based microbiota analysis,
clinical samples are usually processed in batches, making it a requirement to store urine
samples after collections. As the interest in urinary microbiota grows, it will become
increasingly crucial to develop a standardised operating protocol (SOP) for the handling
of urine samples.
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In most biobank sample handling SOPs, urine samples are collected and stored for
biomarker detection. Therefore, relatively low volumes are typically captured, and no
precautions are taken to maintain the viability of microorganisms (Elliott & Peakman,
2008). In our study, we showed that these conditions are not optimal for microbiota
studies. Given the relatively low human and microbial cell numbers in a urine sample, the
volume requirement to capture amounts of microbial gDNA required for a reasonable
analysis is higher than metabolites analysis. Roewer et al. reported that 200 ml of urine
are required to perform a human DNA type with multilocus probes (Roewer et al., 1990)
. Brinkman et al. showed that 10 ml of the urine sample are generally insufficient to
perform DNA polymorphism using Southern blotting (Brinkmann et al., 1992) . In our
study, urine samples with a volume higher than 20 ml seem to have a decent
representation of the urinary microbiota profiles. As a growing number of microbiome
biobank being established (“Harvard Chan School awarded $4.9 million to create
microbiome biobank,” the “PennCHOP Microbiome Program,” webpage) , our results
could be helpful to set their urine sample collection and storage SOPs.

5.2.2 Longitudinal stability of urinary microbiota
In our study, we showed that the urinary microbiota from one donor when analysed at
different time points over three months have high similarity, but much less so than urine
samples from other donors of similar gender and age. We thus can infer that the urinary
microbiota has its stability and resilience as an ecosystem. To our knowledge, this is no
previous study on the ecological stability of the urinary microbiota, but multiple studies
demonstrated the ability of gut microbiota to recover after a pathological condition or
iatrogenic procedures (David et al., 2015; Dethlefsen & Relman, 2011; Fukuyama et al.,
2017; Raymond et al., 2016) . Similarly, we also demonstrated the recovery of urinary
microbiota after lithotripsy surgery in Chapter four. Reported factors contributing to the
stability of gut microbiota includes topical microenvironment, genetic background, diet
and host age, etc. (Relman et al., 2012) . in reverse, gut microbiota profiles also reflect
the health, nutritional and drug administration information of the host (Lozupone et al.,
2012). The urinary microbiota is believed to be shaped and affected by two adjacent
ecosystem: the gastrointestinal tract and the external genitalia (including vagina in
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females), as many common urinary inhabitant microbial species can find their
counterparts in these sites (Dong et al., 2011; Khasriya et al., 2013; D. A. Lewis et al.,
2013; Siddiqui et al., 2011; Willner et al., 2014). Under pathological conditions, these
two sites also serve as a source of microbial invasion and pathogen reservoir which cause
UTI recurrence and relapse (Bao et al., 2014). Other key factors shaping the urinary
microbiota, on the other hand, awaits further studies.
In fact, the stability of the ecosystem is a well-discussed topic in ecology. Elton in 1958
claimed population variability, population recovery, ease of invasion and the
consequences of invasion as aspects and components of ecosystem stability (Elton et al.,
2000). Pimm et al. set a few criteria of ecosystem stability, including parameters showing
the system returning to previous equilibrium after displacement, the time for the system
to return to equilibrium is relatively short, the main parameters of a given system remains
stable during a displacement, the system has the drive against the displacement, and the
variation of main parameters over time is limited (Pimm et al., 1991). In our study, the
urinary microbiota demonstrated its resilience as its alpha and beta diversity index
(Shannon’s index and Weight UniFrac distance scores) maintained low variation level
throughout lithotripsy surgery and could return to the pre-disturbance equilibrium in a
relatively short period (three months or shorter). Recognizing this resilience of urinary
microbiota is crucial when further investigating how displacing events (such as
antibiotics and surgical procedures as discussed in Chapter four) affect the urinary
microbiota and the degree of resilience of urinary microbiota beyond which it can’t
restore the pre-disturbance conditions.

5.3 Bacteria in metabolic urinary stones
In chapter four, we showed that some of the non-infectious, calcium-based metabolic
urinary stones could also harbour bacteria, as can be observed in immediate postoperative
urine samples, despite that all these patients have a negative preoperative urine culture. In
fact, several other studies also reported bacteria in metabolic urinary stones. McCartney
et al. reported that among 16 patients with calcium oxalate stones and negative
preoperative urine culture, four of them has positive culture results on their stone samples
(McCartney et al., 1985). Gault et al. investigated all culture-positive urine stone samples
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of 258 patients, and found only 43% of kidney stones, none of the ureteric stones and
50% of the bladder stones contained magnesium ammonium phosphate composition
(Gault et al., 1995). Hugosson et al. performed stone and urine cultures from 215 patients
and found among all calcium oxalate phosphate stones 32% has positive stone cultures
(Hugosson et al., 1990). These results suggest that urinary stone of any composition
could harbour bacteria and release them during lithotripsy. In our study, we observed a
“bacterial fluctuation” in immediate postoperative urine samples which contained
microbial species that could not be detected in preoperative samples. Interestingly, the
OTUs that showed fluctuation in sequencing correlated with the culture results of stone
and pelvic urine samples, which further confirmed that the source of these is bacteria
likely liberated from the stone. We also noticed that stones with routine type culture
analysis that were positive seemed to have a broader spectrum of microbial species
identified by 16S rRNA gene sequencing than those that didn’t, potentially demonstrating
the ability of sequencing-based techniques to characterise microbial populations that are
not cultivated during routine analysis.
The findings of bacteria in metabolic stone arouse questions of the role bacteria in the
metabolic stone formation and whether they a nidus for inflammation leading to crystal
nucleation. Clinical studies found that urinary stone patients are more likely to have
UTIs, even though such stones may not cause an obstruction (Holmgren et al., 1989;
Hugosson et al., 1989). Interestingly, the most common metabolic stone-associated
bacteria are E.coli, while Proteus species are more common in struvite stones (Gault et
al., 1995). Barr-Beare et al. showed in a rodent model that E.coli infection caused
increased kidney calcium oxalate deposits (Barr-Beare et al., 2015). The exact
mechanism of E.coli inducing metabolic stone formation has yet to be elucidated and
beyond the scope of this study.

5.4 Value of voided urine samples in studying the kidney
stone microbiota and its use in predicting postoperative
infective complications
Although most patients had a negative preoperative urine culture before lithotripsy,
postoperative infective complications are not rare. Many studies have also reported
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infective complications such as bacteriuria in patients with clean voided preoperative
urine cultures. Many urinary stone patients also develop infective complications with a
negative preoperative urine culture (Larsen et al., 1986). Charton et al. documented 35%
of patients receiving PCNL could develop postoperative bacteriuria, while all these
patients had negative preoperative urine culture (Charton et al., 1986). Mariappan et al.
carried out a study among patient receiving ureteroscopic lithotripsy, and found 12 out of
75 included patients developed postoperative bacteriuria (Mariappan & Loong, 2004).
Bratell et al. showed that many of the bacterial species cultured from stone samples are
unidentifiable on voided preoperative urine samples, emphasizing the importance of
stone cultures (Bratell et al., 1990). Of note, in our studies, most patients had negative
postoperative urine cultures by routine methods, but 16S rRNA gene sequencing could
still identify evidence of bacteria liberated from the stone. These results suggested
metabolic stones release bacteria during lithotripsy, and in many cases, it stayed below
clinical detection range. In fact, the threshold of a routine urine culture is always under
some controversy. The commonly used 105 colony forming units (CFU)/mL potentially
miss many clinically significant infections, and there are also recommendations favouring
a threshold of 103 CFU/mL (Jungwirth et al., 2012; Schmiemann, Gebhardt, Matejczyk,
& Hummers-Pradier, 2009). Both of these are subjective determinants. These
controversies to some extent reflect the difficulty of differentiating the pathogens from
the bladder or kidney from commensal microbes in urethral and genitalia when using
voided urine samples. This issue also presents when screening bacteriuria in stone
patients. Several studies have reported that the microbes isolated from the stone culture
cannot be identified from voided urine samples (Mariappan et al., 2005; Mufarrij et al.,
2012; Songra et al., 2016). In our study of the paired sequencing of stone and urine
samples, we can see that OTUs that predominated in the stone sequencing results may
only occupy a small proportion in the voided urine sample, with the remaining reads
attributed to the urethra and genitalia-associated species. These may be part of the
reasons why people claim that voided urine has inferior performance in detection of
bacteria in stones. Lewi et al. showed that the positive rate of preoperative voided urine,
stone sample and pelvic urine cultures are 29%, 38% and 30% respectively, with the
voided urine sample to be the lowest (Lewi et al., 1984). The advantage of the voided
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urine sample, however, is that (a) it can be obtained non-invasively, and (b). it can be
obtained preoperatively for risk evaluation of infective complications. In our study, none
of the six patients who had their stone samples sequenced had positive post-operative
urine culture when analyzed by standard culture techniques, however, for the two of the
patients that had positive stone culture and sequencing results, microbial species that
presented in stone samples also had their OTUs increased in relative abundance in the
sequencing results. These results suggested that sequencing-based techniques could
increase the sensitivity to detect bacteria release from stone during lithotripsy with voided
urine samples.

5.5 Future directions
Detection of microorganisms in very low microbial biomass is always challenging,
especially when the microbes are fastidious. In our study, we utilised sequencing-based
techniques to identify the DNA of these microbes in kidney tissues, and undertook
methodologies to limit contamination by using techniques such as PMA to deactivate any
extracellular DNA. We then confirmed many of these microbes with enhanced culture
techniques. The disadvantage of this strategy is the risk of contamination during sample
handling. A more direct method would be using staining methods that have live/dead
differentiation abilities, for sample the viability stains that based on membrane integrity,
then visualise the bacteria within a tissue section using confocal microscopy. In this way,
bacteria could be visualised in situ, making it possible to identify their inhabiting locus
within a given tissue.
For the stability and resilience of urinary microbiota, one aspect that was not covered in
our present study is the “elasticity” of the urinary microbiota, i, the degree of disturbance
or displacement to the urinary microbiota that it could be still able to restore, and the rate
at which the microbiota returns to its previous conditions. In our study, most of the
participants maintained their urinary microbiota stability partly because they are either
healthy individuals or uncomplicated urinary stone patient with relatively low risk of
severe disturbance. How urinary microbiota responds to a more severe condition,
including chronic infection with anatomical abnormalities, long-term foreign body
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implantation, direct connection with gastrointestinal tract such as fistula or urinary
diversion awaits further study.
To carry on studies on roles of bacteria on the metabolic stone formation, a crosssectional study should be carried out to explore the incidence of metabolic stones
harbouring bacteria. Multiple studies have reported positive bacterial culture from urinary
samples, but most of these studies have a relatively small sample size (<= 150 donors)
(Sohshang et al., 2000; Takeuchi et al., 1989; Tavichakorntrakool et al., 2012; Yoshida et
al., 1984). Microbiological screening of a larger cohort needs to be applied to confirm the
observation that E.coli is the most commonly found microorganism in metabolic stones.
There have been reports that inflammation could promote urinary stone formation
(Ghazali et al., 1997; Rule et al., 2009). The most extreme case would be the matrix
stones, which mainly consists of inflammatory proteins (Canales et al., 2009). Metabolic
stones in the kidney may also induce inflammation by mechanic effects or urinary
obstruction through Il-1β released by dendritic cells, and urine Il-6 would also be
elevated (Canales et al., 2010; Mulay et al., 2012). The innate immune reaction may later
be activated, and the immune proteins may form the inner core of the stone which in turn
facilitate crystalluria precipitation (Mushtaq et al., 2007). How bacteria may modulate the
inflammation cascade, and the interaction of immune proteins would be the interest of
further studies.

5.6 Final statement
As our results and other studies have shown, the study of samples with high host DNA
and low microbial biomass is technically challenging. Described by Joanne et al. as
“Schrödinger’s microbes”, analysis of microbial composition and function in these
samples is fraught with complications. Extra caution, meticulously optimised methods
and combination with enhanced culture methods are required to obtain a relatively
accurate result. Despite these limitations, sequencing-based techniques remain as a novel
and sensitive methods for microbiota research, and have the potential for further clinical
application.
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Appendices
Appendix A: Primer details for 16S rRNA gene amplification
The target of these primer sets was the V4/V6 hypervariable region of the 16S rRNA
gene: V4-forward, 5’
ACACTCTTTCCCTACACGACGCTCTTCCGATCTnnnn(8)GTGCCAGCMGCCGCG
GTAA 3’; and V4-reverse, 5’
CGGTCTCGGCATTCCTGCTGAACCGCTCTTCCGATCTnnnn(8)GGACTACHVGG
GTWTCTAAT 3’. V6-forward,
5′ACACTCTTTCCCTACACGACGCTCTTCCGATCTnnnn(8)CWACGCGARGAACC
TTACC3′; and V6-reverse,
5′CGGTCTCGGCATTCCTGCTGAACCGCTCTTCCGATCTnnnn(8)ACRACACGAG
CTGACGAC3′.
In the primers, the first 35-37 capitalized letters were the Illumina paired-end sequencing
adapters, “nnnn” were four random nucleotides, and “(8)” was a specific sample barcode
region which allows for sample multiplexing.
Appendix B: PCR reaction system of V4 amplicon library construction
The PCR was performed in a 42-μl reaction system, including 2 μl of DNA template (for
negative controls nuclease-free water was used instead), 0.15 μg/μl of bovine serum
albumin, 20 μl of 2× GoTaq hot-start colorless master mix (Promega), 10 μl of left and
right primers (3.2 pmol/μl). Samples were amplified individually with an Eppendorf
Mastercycler under the following conditions: initial denaturation at 95°C for 2 min
followed by 25 cycles of 95°C for 1 min, 55°C for 1 min, and 72°C for 1 min.
Appendix C: The exact workflow for 16S sequencing
This part is adapted from the supplementary material with permission of
Bian G, Gloor GB, Gong A, Jia C, Zhang W, Hu J, Zhang H, Zhang Y, Zhou Z, Zhang J, Burton JP,
Reid G, Xiao Y, Zeng Q, Yang K, Li J. 2017. The gut microbiota of healthy aged Chinese is similar
to that of the healthy young. mSphere 2:e00327-17. https://doi.org/10.1128/mSphere.0032717.
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Step 1: Download and de-compress the MiSeq reads. Place the reads into the
reads/directory. Reads are compressed with 7Zip. The following commands were used to
decompress the file:
7z e filename
gunzip XthRun_S1_L001_R1_00.fastq.gz
Step 2: Overlap the reads with pandaseq v2.5. An example command for this with a
minimum overlap of 30 nucleotides is below. This command is appropriate for the V4
amplimers:
pandaseq -g pandaseq_log.txt -T 8 -f Burton-576_S1_L001_R1_001.fastq -r Burton576_S1_L001_R2_001.fastq -o 30 -w ps_overlapped30.fastq -F &
Step 3: Run the workﬂow pipeline:
./workflow.sh name 0.97 V4EMB
3.1 extracting out the barcodes and primers associated with a particular samples.txt ﬁle.
Output is a tabbed format ﬁle with the ﬁelds: read ID, sample ID primer sequence primer
barcode q-score
$BIN/process_miseq_reads.pl $BIN samples.txt reads/overlapped.fastq $primer 8 0
$name T > $rekeyedtabbedfile
3.2 Making a fasta ﬁle of all identical sequences (ISU), and an index of those sequences
$BIN/group_gt1.pl $rekeyedtabbedfile $name
3.3 Clustering at 97% identity using usearch (i.e., make OTU), also performs chimera
ﬁlter singleton reads are excluded
$BIN/usearch -cluster_otus data_$name/groups_uclust.fa -otu_radius_pct 3 -otus
data_$name/clustered_otus_usearch.fa
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$BIN/usearch -usearch_global $groups_fa_file -db
data_$name/clustered_otus_usearch.fa -strand plus -id 0.97 -uc $c95file
3.4 Regenerating the tabbed reads ﬁle with each read tagged as to its OTU and ISU group
membership
$BIN/map_otu_isu_read_us7.pl $c95file $reads_in_groups_file
$rekeyedtabbedfile > $mappedfile
3.5 Making two tables of counts in the analysis directory for OSU and ISU sequences
gather the seed sequences for each OTU. Transpose the dataset for ease of import into
QIIME
$BIN/get_tag_pair_counts_ps.pl $mappedfile $CUTOFF $name
$BIN/get_seed_otus_uc7.pl $c95file $groups_fa_file
analysis_$name/OTU_tag_mapped.txt > analysis_$name/OTU_seed_seqs.fa
Rscript $BIN/OTU_to_QIIME.R analysis_$name
3.6 Using mothur to annotate the OTU sequences against the Silva database (v119)
mothur "#classify.seqs(fasta=analysis_$name/OTU_seed_seqs.fa,
template=$TEMPLATE, taxonomy=$TAXONOMY, cutoff=70, probs=T, processors=4)"
$BIN/add_taxonomy_mothur.pl $TAX_FILE
analysis_$name/td_OTU_tag_mapped.txt >
analysis_$name/td_OTU_tag_mapped_lineage.txt
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Appendix C: Recipe of microbiological culture media used in the thesis
Columbia Blood Agar (CBA)
The CBA was made with Difco™ CBA Base, contents were showed in g/L
Pancreatic Digest of Casein
10.0
Proteose Peptone No.3
5.0
Yeast Extract
5.0
Beef Heart, Infusion from 500g
3.0
Corn Starch
1.0
Sodium Chloride
5.0
Agar
15.0
5% volume of sterile defibrinated sheep blood were added to the base after autoclave
Columbia CNA Agar, g/L (Final pH 7.3 +/- 0.2 at 25 ℃)
Pancreatic Digest of Casein
12.0
Peptic Digest of Animal Tissue
5.0
Yeast Extract
3.0
Beef Extract
3.0
Corn Starch
1.0
Sodium Chloride
5.0
Agar
13.5
Colistin
0.01
Nalidixic Acid
0.01
5% volume of sterile defibrinated sheep blood were added to the base after autoclave
Chocolate Agar ingredients, g/L (Final pH 7.2 +/- 0.2 at 25 ℃)
Proteose Peptone
Sodium Chloride
Dipotassium Phosphate
Dextros
Agar

20.0
5.0
0.50
0.50
15.0

Anaerobic Blood Agar ingredients, g/L
Casein Peptone
Sodium Chloride
Soy Peptone
Yeast Extract
L-Cystine
Vitamin K
Hemin
Agar

15
5
5
5
0.4
0.01
0.005
20
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MacConkey Agar ingredients, g/L
Peptone
Proteose peptone
Lactose
NaCl
Crystal Violet
Neutral Red
Bile Salts
Agar

17.0
3.0
10.0
5.0
0.001
0.03
1.5
13.5

Anaerobic Phenylethyl Alcohol (PEA) Agar, g/L
Pancreatic and Enzymatic Digests of Casein 15.0
Papaic Digest of Soybean Meal
5.0g
Sodium Chloride
5.0g
Yeast Extract
5.0g
Phenylethanol
2.5g
Reducing Agents/Peroxide Inhibitors
1.5g
Vitamin K
0.01
Hemin
0.005
Cystine
0.0004
Agar
15.0
5% volume of sterile defibrinated sheep blood were added to the base after autoclave
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